KR102283326B1 - Cosmetic compositions containing Fermented products of Lactobacillus, Fermented products of Lactococcus, Sacchromyces peptide, Lactobacillus acidophilus/grape ferment - Google Patents
Cosmetic compositions containing Fermented products of Lactobacillus, Fermented products of Lactococcus, Sacchromyces peptide, Lactobacillus acidophilus/grape ferment Download PDFInfo
- Publication number
- KR102283326B1 KR102283326B1 KR1020190061929A KR20190061929A KR102283326B1 KR 102283326 B1 KR102283326 B1 KR 102283326B1 KR 1020190061929 A KR1020190061929 A KR 1020190061929A KR 20190061929 A KR20190061929 A KR 20190061929A KR 102283326 B1 KR102283326 B1 KR 102283326B1
- Authority
- KR
- South Korea
- Prior art keywords
- fermented product
- lactobacillus
- lactococcus
- grape
- lactobacillus acidophilus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 60
- 241000186660 Lactobacillus Species 0.000 title claims abstract description 58
- 229940039696 lactobacillus Drugs 0.000 title claims abstract description 57
- 108090000765 processed proteins & peptides Proteins 0.000 title claims abstract description 57
- 240000001046 Lactobacillus acidophilus Species 0.000 title claims abstract description 54
- 235000013956 Lactobacillus acidophilus Nutrition 0.000 title claims abstract description 54
- 241000194036 Lactococcus Species 0.000 title claims abstract description 54
- 229940039695 lactobacillus acidophilus Drugs 0.000 title claims abstract description 54
- 235000009754 Vitis X bourquina Nutrition 0.000 title claims abstract description 49
- 235000012333 Vitis X labruscana Nutrition 0.000 title claims abstract description 49
- 235000014787 Vitis vinifera Nutrition 0.000 title claims abstract description 49
- 239000002537 cosmetic Substances 0.000 title claims abstract description 43
- 240000006365 Vitis vinifera Species 0.000 title abstract description 42
- 102000004196 processed proteins & peptides Human genes 0.000 claims abstract description 56
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims abstract description 53
- 229920001184 polypeptide Polymers 0.000 claims abstract description 53
- 239000002502 liposome Substances 0.000 claims abstract description 42
- 235000015112 vegetable and seed oil Nutrition 0.000 claims abstract description 33
- 239000008158 vegetable oil Substances 0.000 claims abstract description 30
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 claims abstract description 24
- 239000000787 lecithin Substances 0.000 claims abstract description 24
- 235000010445 lecithin Nutrition 0.000 claims abstract description 24
- 229940067606 lecithin Drugs 0.000 claims abstract description 24
- 239000004480 active ingredient Substances 0.000 claims abstract description 15
- 230000003110 anti-inflammatory effect Effects 0.000 claims abstract description 11
- 239000000047 product Substances 0.000 claims description 123
- 230000003020 moisturizing effect Effects 0.000 claims description 25
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 15
- -1 skin Substances 0.000 claims description 15
- 239000006071 cream Substances 0.000 claims description 14
- 230000003078 antioxidant effect Effects 0.000 claims description 11
- 239000006210 lotion Substances 0.000 claims description 10
- 239000003921 oil Substances 0.000 claims description 9
- 235000019198 oils Nutrition 0.000 claims description 9
- 239000004094 surface-active agent Substances 0.000 claims description 9
- 241000219094 Vitaceae Species 0.000 claims description 8
- 235000021021 grapes Nutrition 0.000 claims description 8
- 239000000843 powder Substances 0.000 claims description 7
- 239000000463 material Substances 0.000 claims description 5
- 238000000034 method Methods 0.000 claims description 3
- 239000000470 constituent Substances 0.000 claims description 2
- 238000005538 encapsulation Methods 0.000 claims description 2
- 230000000475 sunscreen effect Effects 0.000 claims description 2
- 239000000516 sunscreening agent Substances 0.000 claims description 2
- 241000219095 Vitis Species 0.000 claims 7
- 235000011894 couscous Nutrition 0.000 claims 1
- 230000000052 comparative effect Effects 0.000 description 51
- 210000003491 skin Anatomy 0.000 description 36
- AFCARXCZXQIEQB-UHFFFAOYSA-N N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(CCNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 AFCARXCZXQIEQB-UHFFFAOYSA-N 0.000 description 28
- 230000000694 effects Effects 0.000 description 27
- 238000002474 experimental method Methods 0.000 description 18
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 18
- 238000009472 formulation Methods 0.000 description 16
- VZSRBBMJRBPUNF-UHFFFAOYSA-N 2-(2,3-dihydro-1H-inden-2-ylamino)-N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]pyrimidine-5-carboxamide Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C(=O)NCCC(N1CC2=C(CC1)NN=N2)=O VZSRBBMJRBPUNF-UHFFFAOYSA-N 0.000 description 15
- 239000000523 sample Substances 0.000 description 15
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 13
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 13
- 238000012360 testing method Methods 0.000 description 13
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 12
- 230000004663 cell proliferation Effects 0.000 description 11
- 238000000855 fermentation Methods 0.000 description 11
- 230000004151 fermentation Effects 0.000 description 11
- 239000003963 antioxidant agent Substances 0.000 description 10
- 235000006708 antioxidants Nutrition 0.000 description 10
- 102000003820 Lipoxygenases Human genes 0.000 description 9
- 108090000128 Lipoxygenases Proteins 0.000 description 9
- NIPNSKYNPDTRPC-UHFFFAOYSA-N N-[2-oxo-2-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(CNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 NIPNSKYNPDTRPC-UHFFFAOYSA-N 0.000 description 9
- 230000002401 inhibitory effect Effects 0.000 description 9
- 201000004624 Dermatitis Diseases 0.000 description 8
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 8
- 210000004027 cell Anatomy 0.000 description 7
- 230000007760 free radical scavenging Effects 0.000 description 7
- 230000006872 improvement Effects 0.000 description 7
- 238000004519 manufacturing process Methods 0.000 description 7
- 239000008213 purified water Substances 0.000 description 7
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 210000002615 epidermis Anatomy 0.000 description 6
- 238000001914 filtration Methods 0.000 description 6
- 235000011187 glycerol Nutrition 0.000 description 6
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 6
- 230000004054 inflammatory process Effects 0.000 description 6
- 239000004615 ingredient Substances 0.000 description 6
- 230000005764 inhibitory process Effects 0.000 description 6
- 230000003859 lipid peroxidation Effects 0.000 description 6
- 238000002360 preparation method Methods 0.000 description 6
- 239000002994 raw material Substances 0.000 description 6
- 206010061218 Inflammation Diseases 0.000 description 5
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 5
- 206010040880 Skin irritation Diseases 0.000 description 5
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 5
- 238000006243 chemical reaction Methods 0.000 description 5
- 230000007423 decrease Effects 0.000 description 5
- 235000014113 dietary fatty acids Nutrition 0.000 description 5
- 238000011156 evaluation Methods 0.000 description 5
- 239000000194 fatty acid Substances 0.000 description 5
- 229930195729 fatty acid Natural products 0.000 description 5
- 229940075529 glyceryl stearate Drugs 0.000 description 5
- 230000001965 increasing effect Effects 0.000 description 5
- 239000001818 polyoxyethylene sorbitan monostearate Substances 0.000 description 5
- 235000010989 polyoxyethylene sorbitan monostearate Nutrition 0.000 description 5
- 150000003254 radicals Chemical class 0.000 description 5
- 230000036556 skin irritation Effects 0.000 description 5
- 231100000475 skin irritation Toxicity 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 4
- MKYBYDHXWVHEJW-UHFFFAOYSA-N N-[1-oxo-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propan-2-yl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(C(C)NC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 MKYBYDHXWVHEJW-UHFFFAOYSA-N 0.000 description 4
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 4
- 229920002125 Sokalan® Polymers 0.000 description 4
- 235000021355 Stearic acid Nutrition 0.000 description 4
- 238000002835 absorbance Methods 0.000 description 4
- 230000007815 allergy Effects 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 239000003995 emulsifying agent Substances 0.000 description 4
- 229940075507 glyceryl monostearate Drugs 0.000 description 4
- 239000001963 growth medium Substances 0.000 description 4
- 150000002632 lipids Chemical class 0.000 description 4
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 4
- 235000016709 nutrition Nutrition 0.000 description 4
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 4
- 239000000049 pigment Substances 0.000 description 4
- 239000011148 porous material Substances 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- 239000007921 spray Substances 0.000 description 4
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 4
- 239000008117 stearic acid Substances 0.000 description 4
- 210000000434 stratum corneum Anatomy 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 239000001993 wax Substances 0.000 description 4
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 3
- CUNWUEBNSZSNRX-RKGWDQTMSA-N (2r,3r,4r,5s)-hexane-1,2,3,4,5,6-hexol;(z)-octadec-9-enoic acid Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O CUNWUEBNSZSNRX-RKGWDQTMSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 3
- 102000008186 Collagen Human genes 0.000 description 3
- 108010035532 Collagen Proteins 0.000 description 3
- 102000016942 Elastin Human genes 0.000 description 3
- 108010014258 Elastin Proteins 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- 229920001214 Polysorbate 60 Polymers 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 3
- 230000002421 anti-septic effect Effects 0.000 description 3
- 235000013871 bee wax Nutrition 0.000 description 3
- 239000012166 beeswax Substances 0.000 description 3
- 229940092738 beeswax Drugs 0.000 description 3
- 239000004359 castor oil Substances 0.000 description 3
- 235000019438 castor oil Nutrition 0.000 description 3
- 229960000541 cetyl alcohol Drugs 0.000 description 3
- 229920001436 collagen Polymers 0.000 description 3
- 230000003013 cytotoxicity Effects 0.000 description 3
- 231100000135 cytotoxicity Toxicity 0.000 description 3
- 229920002549 elastin Polymers 0.000 description 3
- 239000000839 emulsion Substances 0.000 description 3
- 239000000686 essence Substances 0.000 description 3
- 239000000706 filtrate Substances 0.000 description 3
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- 239000012535 impurity Substances 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 3
- 229940056211 paraffin Drugs 0.000 description 3
- 239000012188 paraffin wax Substances 0.000 description 3
- 229940113124 polysorbate 60 Drugs 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- 230000037394 skin elasticity Effects 0.000 description 3
- 229960005078 sorbitan sesquioleate Drugs 0.000 description 3
- 235000013599 spices Nutrition 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- KZJWDPNRJALLNS-VPUBHVLGSA-N (-)-beta-Sitosterol Natural products O[C@@H]1CC=2[C@@](C)([C@@H]3[C@H]([C@H]4[C@@](C)([C@H]([C@H](CC[C@@H](C(C)C)CC)C)CC4)CC3)CC=2)CC1 KZJWDPNRJALLNS-VPUBHVLGSA-N 0.000 description 2
- CSVWWLUMXNHWSU-UHFFFAOYSA-N (22E)-(24xi)-24-ethyl-5alpha-cholest-22-en-3beta-ol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(CC)C(C)C)C1(C)CC2 CSVWWLUMXNHWSU-UHFFFAOYSA-N 0.000 description 2
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 2
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 2
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 2
- DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical compound C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 2
- KLEXDBGYSOIREE-UHFFFAOYSA-N 24xi-n-propylcholesterol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CCC)C(C)C)C1(C)CC2 KLEXDBGYSOIREE-UHFFFAOYSA-N 0.000 description 2
- 208000002874 Acne Vulgaris Diseases 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 2
- YDNKGFDKKRUKPY-JHOUSYSJSA-N C16 ceramide Natural products CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)C=CCCCCCCCCCCCCC YDNKGFDKKRUKPY-JHOUSYSJSA-N 0.000 description 2
- LPZCCMIISIBREI-MTFRKTCUSA-N Citrostadienol Natural products CC=C(CC[C@@H](C)[C@H]1CC[C@H]2C3=CC[C@H]4[C@H](C)[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C)C(C)C LPZCCMIISIBREI-MTFRKTCUSA-N 0.000 description 2
- ARVGMISWLZPBCH-UHFFFAOYSA-N Dehydro-beta-sitosterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)CCC(CC)C(C)C)CCC33)C)C3=CC=C21 ARVGMISWLZPBCH-UHFFFAOYSA-N 0.000 description 2
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- 239000004166 Lanolin Substances 0.000 description 2
- 235000019493 Macadamia oil Nutrition 0.000 description 2
- 239000004909 Moisturizer Substances 0.000 description 2
- CRJGESKKUOMBCT-VQTJNVASSA-N N-acetylsphinganine Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(C)=O CRJGESKKUOMBCT-VQTJNVASSA-N 0.000 description 2
- 206010057249 Phagocytosis Diseases 0.000 description 2
- 229920002565 Polyethylene Glycol 400 Polymers 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- ATUOYWHBWRKTHZ-UHFFFAOYSA-N Propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 2
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 2
- 241000235070 Saccharomyces Species 0.000 description 2
- 208000000453 Skin Neoplasms Diseases 0.000 description 2
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 2
- HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 description 2
- 102000019197 Superoxide Dismutase Human genes 0.000 description 2
- 108010012715 Superoxide dismutase Proteins 0.000 description 2
- 235000018936 Vitellaria paradoxa Nutrition 0.000 description 2
- 241001135917 Vitellaria paradoxa Species 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 206010000496 acne Diseases 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 239000000440 bentonite Substances 0.000 description 2
- 229910000278 bentonite Inorganic materials 0.000 description 2
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 2
- SESFRYSPDFLNCH-UHFFFAOYSA-N benzyl benzoate Chemical compound C=1C=CC=CC=1C(=O)OCC1=CC=CC=C1 SESFRYSPDFLNCH-UHFFFAOYSA-N 0.000 description 2
- MJVXAPPOFPTTCA-UHFFFAOYSA-N beta-Sistosterol Natural products CCC(CCC(C)C1CCC2C3CC=C4C(C)C(O)CCC4(C)C3CCC12C)C(C)C MJVXAPPOFPTTCA-UHFFFAOYSA-N 0.000 description 2
- LGJMUZUPVCAVPU-UHFFFAOYSA-N beta-Sitostanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 LGJMUZUPVCAVPU-UHFFFAOYSA-N 0.000 description 2
- NJKOMDUNNDKEAI-UHFFFAOYSA-N beta-sitosterol Natural products CCC(CCC(C)C1CCC2(C)C3CC=C4CC(O)CCC4C3CCC12C)C(C)C NJKOMDUNNDKEAI-UHFFFAOYSA-N 0.000 description 2
- 239000000828 canola oil Substances 0.000 description 2
- 235000019519 canola oil Nutrition 0.000 description 2
- 230000010261 cell growth Effects 0.000 description 2
- 229940106189 ceramide Drugs 0.000 description 2
- ZVEQCJWYRWKARO-UHFFFAOYSA-N ceramide Natural products CCCCCCCCCCCCCCC(O)C(=O)NC(CO)C(O)C=CCCC=C(C)CCCCCCCCC ZVEQCJWYRWKARO-UHFFFAOYSA-N 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 229940107161 cholesterol Drugs 0.000 description 2
- 210000002808 connective tissue Anatomy 0.000 description 2
- 238000012258 culturing Methods 0.000 description 2
- RNPXCFINMKSQPQ-UHFFFAOYSA-N dicetyl hydrogen phosphate Chemical compound CCCCCCCCCCCCCCCCOP(O)(=O)OCCCCCCCCCCCCCCCC RNPXCFINMKSQPQ-UHFFFAOYSA-N 0.000 description 2
- 229940093541 dicetylphosphate Drugs 0.000 description 2
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 2
- 230000002500 effect on skin Effects 0.000 description 2
- 238000004945 emulsification Methods 0.000 description 2
- 230000007613 environmental effect Effects 0.000 description 2
- 239000003344 environmental pollutant Substances 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 239000012091 fetal bovine serum Substances 0.000 description 2
- 210000002950 fibroblast Anatomy 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 229940038487 grape extract Drugs 0.000 description 2
- 229920002674 hyaluronan Polymers 0.000 description 2
- 229960003160 hyaluronic acid Drugs 0.000 description 2
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 2
- 235000019388 lanolin Nutrition 0.000 description 2
- 229940039717 lanolin Drugs 0.000 description 2
- 229940057995 liquid paraffin Drugs 0.000 description 2
- 239000010469 macadamia oil Substances 0.000 description 2
- 230000001333 moisturizer Effects 0.000 description 2
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 2
- VVGIYYKRAMHVLU-UHFFFAOYSA-N newbouldiamide Natural products CCCCCCCCCCCCCCCCCCCC(O)C(O)C(O)C(CO)NC(=O)CCCCCCCCCCCCCCCCC VVGIYYKRAMHVLU-UHFFFAOYSA-N 0.000 description 2
- 230000037311 normal skin Effects 0.000 description 2
- CKQVRZJOMJRTOY-UHFFFAOYSA-N octadecanoic acid;propane-1,2,3-triol Chemical compound OCC(O)CO.CCCCCCCCCCCCCCCCCC(O)=O CKQVRZJOMJRTOY-UHFFFAOYSA-N 0.000 description 2
- 229940049964 oleate Drugs 0.000 description 2
- 239000006072 paste Substances 0.000 description 2
- 230000008782 phagocytosis Effects 0.000 description 2
- 229960005323 phenoxyethanol Drugs 0.000 description 2
- 231100000719 pollutant Toxicity 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 229920001296 polysiloxane Polymers 0.000 description 2
- 230000035755 proliferation Effects 0.000 description 2
- 229960001285 quercetin Drugs 0.000 description 2
- 235000005875 quercetin Nutrition 0.000 description 2
- 229940057910 shea butter Drugs 0.000 description 2
- 239000000377 silicon dioxide Substances 0.000 description 2
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 2
- 229950005143 sitosterol Drugs 0.000 description 2
- NLQLSVXGSXCXFE-UHFFFAOYSA-N sitosterol Natural products CC=C(/CCC(C)C1CC2C3=CCC4C(C)C(O)CCC4(C)C3CCC2(C)C1)C(C)C NLQLSVXGSXCXFE-UHFFFAOYSA-N 0.000 description 2
- 235000015500 sitosterol Nutrition 0.000 description 2
- 201000000849 skin cancer Diseases 0.000 description 2
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 2
- 229950011392 sorbitan stearate Drugs 0.000 description 2
- 229940032094 squalane Drugs 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 238000006467 substitution reaction Methods 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 239000000454 talc Substances 0.000 description 2
- 229910052623 talc Inorganic materials 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 150000003626 triacylglycerols Chemical class 0.000 description 2
- 239000000230 xanthan gum Substances 0.000 description 2
- 235000010493 xanthan gum Nutrition 0.000 description 2
- 229920001285 xanthan gum Polymers 0.000 description 2
- 229940082509 xanthan gum Drugs 0.000 description 2
- JDRSMPFHFNXQRB-IWQYDBTJSA-N (3r,4s,5s,6r)-2-decoxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical group CCCCCCCCCCOC1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O JDRSMPFHFNXQRB-IWQYDBTJSA-N 0.000 description 1
- WNWHHMBRJJOGFJ-UHFFFAOYSA-N 16-methylheptadecan-1-ol Chemical class CC(C)CCCCCCCCCCCCCCCO WNWHHMBRJJOGFJ-UHFFFAOYSA-N 0.000 description 1
- 230000002407 ATP formation Effects 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 208000012657 Atopic disease Diseases 0.000 description 1
- DBFHTTOOJDMDTI-KCMGSBMCSA-N C(CCCCCCCCCCCCCCCCC)(=O)O.CC(=O)[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.C(CCCCCCCCCCCCCCCCC)(=O)O.C(CCCCCCCCCCCCCCCCC)(=O)O.CC(=O)[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO Chemical compound C(CCCCCCCCCCCCCCCCC)(=O)O.CC(=O)[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.C(CCCCCCCCCCCCCCCCC)(=O)O.C(CCCCCCCCCCCCCCCCC)(=O)O.CC(=O)[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO DBFHTTOOJDMDTI-KCMGSBMCSA-N 0.000 description 1
- 240000001548 Camellia japonica Species 0.000 description 1
- 235000006467 Camellia japonica Nutrition 0.000 description 1
- 241000526900 Camellia oleifera Species 0.000 description 1
- 102100035882 Catalase Human genes 0.000 description 1
- 108010053835 Catalase Proteins 0.000 description 1
- 244000060011 Cocos nucifera Species 0.000 description 1
- 235000013162 Cocos nucifera Nutrition 0.000 description 1
- 101800004637 Communis Proteins 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 206010012438 Dermatitis atopic Diseases 0.000 description 1
- 240000003133 Elaeis guineensis Species 0.000 description 1
- 235000001950 Elaeis guineensis Nutrition 0.000 description 1
- 206010015150 Erythema Diseases 0.000 description 1
- 229920002683 Glycosaminoglycan Polymers 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 239000005639 Lauric acid Substances 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 1
- 244000061176 Nicotiana tabacum Species 0.000 description 1
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 240000007817 Olea europaea Species 0.000 description 1
- 235000002725 Olea europaea Nutrition 0.000 description 1
- 235000019482 Palm oil Nutrition 0.000 description 1
- 239000004264 Petrolatum Substances 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 235000003846 Ricinus Nutrition 0.000 description 1
- 241000322381 Ricinus <louse> Species 0.000 description 1
- 206010059516 Skin toxicity Diseases 0.000 description 1
- 229920002385 Sodium hyaluronate Polymers 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- ULUAUXLGCMPNKK-UHFFFAOYSA-N Sulfobutanedioic acid Chemical compound OC(=O)CC(C(O)=O)S(O)(=O)=O ULUAUXLGCMPNKK-UHFFFAOYSA-N 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 239000011149 active material Substances 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 1
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 239000010775 animal oil Substances 0.000 description 1
- 201000008937 atopic dermatitis Diseases 0.000 description 1
- 229940092782 bentonite Drugs 0.000 description 1
- 229960002903 benzyl benzoate Drugs 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 239000001273 butane Substances 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000000378 calcium silicate Substances 0.000 description 1
- 229910052918 calcium silicate Inorganic materials 0.000 description 1
- OYACROKNLOSFPA-UHFFFAOYSA-N calcium;dioxido(oxo)silane Chemical compound [Ca+2].[O-][Si]([O-])=O OYACROKNLOSFPA-UHFFFAOYSA-N 0.000 description 1
- 239000010495 camellia oil Substances 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 229940105657 catalase Drugs 0.000 description 1
- 210000005056 cell body Anatomy 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 230000030833 cell death Effects 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 235000010980 cellulose Nutrition 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 150000005827 chlorofluoro hydrocarbons Chemical class 0.000 description 1
- 229940080421 coco glucoside Drugs 0.000 description 1
- 229940110456 cocoa butter Drugs 0.000 description 1
- 235000019868 cocoa butter Nutrition 0.000 description 1
- 239000003240 coconut oil Substances 0.000 description 1
- 235000019864 coconut oil Nutrition 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 229940117173 croton oil Drugs 0.000 description 1
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 229940073499 decyl glucoside Drugs 0.000 description 1
- 210000004207 dermis Anatomy 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 229940008099 dimethicone Drugs 0.000 description 1
- 239000004205 dimethyl polysiloxane Substances 0.000 description 1
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 1
- 229960001760 dimethyl sulfoxide Drugs 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 231100000321 erythema Toxicity 0.000 description 1
- 150000002191 fatty alcohols Chemical class 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 210000000245 forearm Anatomy 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- FOYKKGHVWRFIBD-UHFFFAOYSA-N gamma-tocopherol acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1 FOYKKGHVWRFIBD-UHFFFAOYSA-N 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- 229940071826 hydroxyethyl cellulose Drugs 0.000 description 1
- 239000005457 ice water Substances 0.000 description 1
- MTNDZQHUAFNZQY-UHFFFAOYSA-N imidazoline Chemical class C1CN=CN1 MTNDZQHUAFNZQY-UHFFFAOYSA-N 0.000 description 1
- 230000008105 immune reaction Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- SUMDYPCJJOFFON-UHFFFAOYSA-N isethionic acid Chemical compound OCCS(O)(=O)=O SUMDYPCJJOFFON-UHFFFAOYSA-N 0.000 description 1
- 230000005722 itchiness Effects 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 229940119170 jojoba wax Drugs 0.000 description 1
- 210000002510 keratinocyte Anatomy 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 229960004488 linolenic acid Drugs 0.000 description 1
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 229940016286 microcrystalline cellulose Drugs 0.000 description 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 1
- 239000008108 microcrystalline cellulose Substances 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- 229940042472 mineral oil Drugs 0.000 description 1
- 210000003470 mitochondria Anatomy 0.000 description 1
- CQDGTJPVBWZJAZ-UHFFFAOYSA-N monoethyl carbonate Chemical compound CCOC(O)=O CQDGTJPVBWZJAZ-UHFFFAOYSA-N 0.000 description 1
- LPUQAYUQRXPFSQ-DFWYDOINSA-M monosodium L-glutamate Chemical compound [Na+].[O-]C(=O)[C@@H](N)CCC(O)=O LPUQAYUQRXPFSQ-DFWYDOINSA-M 0.000 description 1
- IJDNQMDRQITEOD-UHFFFAOYSA-N n-butane Chemical compound CCCC IJDNQMDRQITEOD-UHFFFAOYSA-N 0.000 description 1
- OFBQJSOFQDEBGM-UHFFFAOYSA-N n-pentane Natural products CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 1
- 230000037125 natural defense Effects 0.000 description 1
- 231100000956 nontoxicity Toxicity 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 239000002540 palm oil Substances 0.000 description 1
- 229940066842 petrolatum Drugs 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- 239000010773 plant oil Substances 0.000 description 1
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920005862 polyol Polymers 0.000 description 1
- 150000003077 polyols Chemical class 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- 229940079988 potassium cocoyl glycinate Drugs 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 239000001294 propane Substances 0.000 description 1
- 239000003380 propellant Substances 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 239000002516 radical scavenger Substances 0.000 description 1
- NPCOQXAVBJJZBQ-UHFFFAOYSA-N reduced coenzyme Q9 Natural products COC1=C(O)C(C)=C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)C(O)=C1OC NPCOQXAVBJJZBQ-UHFFFAOYSA-N 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 206010039073 rheumatoid arthritis Diseases 0.000 description 1
- 229940071089 sarcosinate Drugs 0.000 description 1
- FSYKKLYZXJSNPZ-UHFFFAOYSA-N sarcosine Chemical compound C[NH2+]CC([O-])=O FSYKKLYZXJSNPZ-UHFFFAOYSA-N 0.000 description 1
- 210000002374 sebum Anatomy 0.000 description 1
- 230000008591 skin barrier function Effects 0.000 description 1
- 230000037380 skin damage Effects 0.000 description 1
- 230000036620 skin dryness Effects 0.000 description 1
- 230000036559 skin health Effects 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 229940083542 sodium Drugs 0.000 description 1
- 229940079781 sodium cocoyl glutamate Drugs 0.000 description 1
- 229940010747 sodium hyaluronate Drugs 0.000 description 1
- 229940083608 sodium hydroxide Drugs 0.000 description 1
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 229960004274 stearic acid Drugs 0.000 description 1
- 239000012089 stop solution Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
- 229940104261 taurate Drugs 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- CBDKQYKMCICBOF-UHFFFAOYSA-N thiazoline Chemical compound C1CN=CS1 CBDKQYKMCICBOF-UHFFFAOYSA-N 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 230000032258 transport Effects 0.000 description 1
- LADGBHLMCUINGV-UHFFFAOYSA-N tricaprin Chemical compound CCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCC)COC(=O)CCCCCCCCC LADGBHLMCUINGV-UHFFFAOYSA-N 0.000 description 1
- YNJBWRMUSHSURL-UHFFFAOYSA-N trichloroacetic acid Chemical compound OC(=O)C(Cl)(Cl)Cl YNJBWRMUSHSURL-UHFFFAOYSA-N 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- 229940040064 ubiquinol Drugs 0.000 description 1
- QNTNKSLOFHEFPK-UPTCCGCDSA-N ubiquinol-10 Chemical compound COC1=C(O)C(C)=C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)C(O)=C1OC QNTNKSLOFHEFPK-UPTCCGCDSA-N 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 230000037373 wrinkle formation Effects 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/14—Liposomes; Vesicles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/55—Phosphorus compounds
- A61K8/553—Phospholipids, e.g. lecithin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
- A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/99—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from microorganisms other than algae or fungi, e.g. protozoa or bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/52—Stabilizers
- A61K2800/522—Antioxidants; Radical scavengers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/85—Products or compounds obtained by fermentation, e.g. yoghurt, beer, wine
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Dermatology (AREA)
- Cosmetics (AREA)
Abstract
본 발명은 락토바실러스발효물, 락토코커스발효물, 효모폴리펩타이드, 락토바실러스 아시도필루스 포도발효물 등 유효성분이 봉입된 리포좀을 포함한 화장료 조성물을 제공하여 우수한 피부 보습력과 항산화 및 항염효과를 증대시키는 것을 목적으로 한다. 식물성오일과 레시틴으로 안정화시킨 리포좀에 락토바실러스발효물, 락토코커스발효물, 효모폴리펩타이드, 락토바실러스 아시도필루스 포도발효물을 유효성분으로 봉입하여 이것을 포함한 화장료 조성물을 제조함으로써 피부 보습력과 항산화 및 항염효과를 증대시킨다.The present invention provides a cosmetic composition comprising liposomes in which active ingredients such as Lactobacillus fermented product, Lactococcus fermented product, yeast polypeptide, Lactobacillus acidophilus grape fermented product, etc. aim to Lactobacillus fermented product, lactococcus fermented product, yeast polypeptide, and Lactobacillus acidophilus grape fermented product are encapsulated in liposomes stabilized with vegetable oil and lecithin as active ingredients, and a cosmetic composition containing them is prepared by Increases anti-inflammatory effect.
Description
본 발명은 락토바실러스발효물, 락토코커스발효물, 효모폴리펩타이드, 락토바실러스 아시도필루스 포도발효물 등 유효성분이 봉입된 리포좀을 포함한 화장료 조성물에 관한 것으로, 더 자세하게는 식물성오일과 레시틴으로 안정화시킨 리포좀에 락토바실러스발효물, 락토코커스발효물, 효모폴리펩타이드, 락토바실러스 아시도필루스 포도발효물을 유효성분으로 봉입하여 이것을 포함한 화장료 조성물을 제조함으로써 피부 보습력과 항산화 및 항염효과를 증대시킨 화장료 조성물에 관한 것이다.The present invention relates to a cosmetic composition comprising liposomes in which active ingredients such as Lactobacillus fermented product, Lactococcus fermented product, yeast polypeptide, and Lactobacillus acidophilus grape fermented product are encapsulated. Lactobacillus fermented product, Lactococcus fermented product, yeast polypeptide, and Lactobacillus acidophilus grape fermented product are encapsulated in liposomes as active ingredients to prepare a cosmetic composition containing them, thereby enhancing skin moisturizing power, antioxidant and anti-inflammatory effects. is about
일반적으로 피부는 외부 환경에 직접적으로 노출되는 신체 부위로서, 과도한 자외선이나 오염물질 등에 노출되면 홍반, 부종, 가려움 등의 피부자극 및 염증반응이 유발된다. 이러한 피부 트러블은 미관상 문제가 될 뿐만 아니라, 염증반응과정에서 생성되는 물질들이 부수적으로 색소 침착을 일으키고, 피부 탄력에 관여하는 콜라겐(collagen), 엘라스틴(elastin), 히알루로산(Hyaluronic acid), 뮤코다당류(Mucopolysaccharide) 등의 붕괴를 촉진시키는 등 피부손상을 발생시킨다. In general, the skin is a part of the body directly exposed to the external environment, and when exposed to excessive ultraviolet rays or pollutants, skin irritation such as erythema, edema, itching, and inflammatory reactions are induced. These skin troubles are not only a cosmetic problem, but also the substances produced during the inflammatory reaction cause pigmentation incidentally, and collagen, elastin, hyaluronic acid, and muco are involved in skin elasticity. It causes skin damage by accelerating the breakdown of mucopolysaccharides.
이러한 피부 손상에는 1950년대 중반 디 하만(D. Harman)에 의해 제시된 자유라디칼 이론에 따라, 자유라디칼은 세포를 파괴하거나 피부 진피층의 결합조직을 절단하거나 교차 결합을 일으키므로 진피층의 수분유지를 어렵게 하고 주름형성, 피부암, 세포 살상, 류마티스성 관절염, 아토피성 피부염, 여드름 등 여러 가지 문제를 발생시킨다. According to the free radical theory presented by D. Harman in the mid-1950s, free radicals destroy cells, cut the connective tissue of the dermal layer of the skin, or cause cross-linking, making it difficult to maintain moisture in the dermal layer and It causes various problems such as wrinkle formation, skin cancer, cell death, rheumatoid arthritis, atopic dermatitis, and acne.
자유라디칼이 생성되는 원인은 백혈구의 식작용, 미토콘드리아에서의 ATP 생산과정 중 전자 전달계, 미엘로퍼 옥사이드(Myeloper Oxide(MPO))의 작용, 자외선, 담배, 정상적인 대사 과정, 스트레스, 공해 물질, 세균으로 알려져있다. The causes of free radicals are known as phagocytosis of white blood cells, electron transport system during ATP production in mitochondria, the action of Myeloper Oxide (MPO), ultraviolet rays, tobacco, normal metabolic processes, stress, pollutants, and bacteria. there is.
상기 식작용이란 세포체가 이물 혹은 박테리아 등을 자기 체내에 받아들여서 이것을 분해, 무해화(無害化)하는 작용을 말한다.The phagocytosis refers to an action in which the cell body receives foreign substances or bacteria into its own body and decomposes and detoxifies it.
물론 인체에는 항산화 물질(라디칼 소거제)인 슈퍼옥사이드 디스뮤타제 (SuperOxide Dismutase : SOD), 카탈라아제, 비타민 E, 비타민 C, 유비퀴놀 (Uviquinol)있지만, 나이, 공해, 자외선, 스트레스에 의해 항산화 체계가 무력화되고, 자유라디칼이 점차 증가하게 된다. Of course, the human body has superoxide dismutase (SOD), catalase, vitamin E, vitamin C, and ubiquinol, which are antioxidants (radical scavengers). It is neutralized, and free radicals gradually increase.
증가된 자유라디칼은 진피의 결합조직인 콜라겐(Collagen), 엘라스틴 (Elastin), 히아루론산(Hyaluronic acid), 뮤코다당류(Mucopolysacchride) 등을 파괴하여 세포막의 지질 부분을 산화시켜 세포의 파괴 현상이 발생되어 피부주름, 피부염, 여드름, 피부암의 질병을 유발하게 되는 것이다. The increased free radicals destroy the connective tissue of the dermis such as collagen, elastin, hyaluronic acid, mucopolysacchride, etc. , dermatitis, acne, and skin cancer.
피부는 구조적으로 표피층의 수분 유지기능이 상실될 경우 정상적인 피부 보습을 유지할 수가 없게 되면서 피부탄력과 건강을 모두 잃게 된다. 우리 몸은 생명체를 유지하는데 필요한 물이 대부분을 차지하고 있으며, 정상적인 피부에서 수분은 체내에 70%, 피부 표피의 각질층에 10 ~ 20%를 차지하고 있어 피부를 구성하는 세포와 고유한 단백질이 정상적인 기능을 할 수 있도록 한다. When the skin loses its ability to retain moisture in the epidermal layer structurally, it cannot maintain normal skin moisture and loses both skin elasticity and health. Most of the water our body needs to sustain life takes up 70% of water in the body and 10 to 20% in the stratum corneum of the skin epidermis in normal skin, so the cells and unique proteins that make up the skin are able to function normally. make it possible
반면, 피부 표피의 각질층에 수분이 10% 미만으로 낮아지게 되면 피부의 탄력과 유연성이 사라지고 건조하고 거칠어지게 된다. 이는 피부 건성화를 유발하여 염증과 트러블의 원인이 되고 각질형성세포와 섬유아세포의 활성이 감소하게 된다.On the other hand, when the moisture in the stratum corneum of the epidermis is lowered to less than 10%, the elasticity and flexibility of the skin disappear and the skin becomes dry and rough. This causes skin dryness, which causes inflammation and trouble, and the activity of keratinocytes and fibroblasts decreases.
또한, 수분보유력이 낮아지면서 피부탄력의 감소는 피부의 모공벽을 지지하던 콜라겐과 엘라스틴의 탄력이 감소하면서 모공을 조여주는 힘이 약해져 모공도 늘어나게 된다. 늘어난 모공과 건조함에 피부 장벽도 무너지면서 세균의 침입하여 염증을 발생시키기 때문에 무엇보다도 피부 각질층의 수분함량을 유지하는 것이 매우 중요하다.In addition, the decrease in skin elasticity as the water holding power decreases, the elasticity of collagen and elastin, which supported the pore wall of the skin, decreases, and the power to tighten the pores is weakened and the pores increase. It is very important to maintain the moisture content of the stratum corneum above all else because the skin barrier breaks down due to the increased pores and dryness, and bacteria invade and cause inflammation.
현재 피부 내 수분 소실을 막기 위하여 바셀린, 라놀린, 코코아 버터, 미네랄 오일, 호호바오일, 시어버터, 실리콘 등과 같은 소수성 물질인 폐색제(occlusive agent)를 사용하고 있으며, 화장품 제조를 위하여 종래의 기술로는 소듐 라우릴 설페이트(Sodium Lauryl Sulfate), 디메틸 술폭사이드(Dimethyl Sulfoxide), 크로톤 오일(Croton Oil) 및 수산화나트륨 등 20에서 50여 종의 일반원료들을 사용하고 있다. 상기 원료들이 제품에 첨가되면 피부자극은 물론 가려움증, 알러지, 피부염증 등 면역반응을 동반하여 각질층은 물론 경표피 수분 손실(Transepidemal Water Loss)이 증가하게 되어 피부염증을 유발시키는 원인이 되기도 한다. Currently, occlusive agents, which are hydrophobic substances such as petrolatum, lanolin, cocoa butter, mineral oil, jojoba oil, shea butter, and silicone, are used to prevent moisture loss in the skin. About 20 to 50 kinds of general raw materials such as sodium lauryl sulfate, dimethyl sulfoxide, croton oil and sodium hydroxide are used. When the above ingredients are added to the product, not only skin irritation but also immune reactions such as itchiness, allergy, and skin inflammation are accompanied by an increase in the stratum corneum as well as transepidemal water loss, which causes skin inflammation.
이에 화장료 조성물에 함유되는 종래의 보습제는 피부에 자극과 염증을 동반 트러블을 유발시키는 부작용이 동반됨에 따라 피부 보습 효과, 보호 효과 등을 얻는데 한계가 있다.Accordingly, the conventional moisturizing agent contained in the cosmetic composition has a limitation in obtaining a skin moisturizing effect, a protective effect, etc. as it is accompanied by a side effect of causing trouble accompanied by irritation and inflammation to the skin.
이를 보완하고자 화장품에 피지와 유사한 구조의 성분이나 천연 보습 인자(NMF), 수산기(-OH)가 3개인 3가 알코올의 폴리올 등을 사용하여 보습제로의 역할을 하도록 첨가하였다.To supplement this, a component with a structure similar to sebum, a natural moisturizing factor (NMF), a polyol of a trihydric alcohol having three hydroxyl groups (-OH), etc. were added to act as a moisturizer.
하지만, 지리적 또는 환경적인 상황에 따라 온도와 습도의 영향으로 사용감에 끈적임이나 불쾌감을 느끼게 하기도 하며, 때에 따라 역으로 수분을 빼앗기는 문제가 발생되기도 하였다.However, depending on the geographical or environmental conditions, the effect of temperature and humidity may cause stickiness or discomfort to the feeling of use, and in some cases, a problem of depriving moisture conversely occurred.
이러한 문제를 해결하고자 최근에는 동·식물부터 미생물에 이르기까지 천연 유래 생리활성소재를 개발하고 이를 화장료에 도입하여 피부 자체의 고유방어 기능을 유지 향상시킴으로써 피부 내 수분소실을 억제하고 탄력과 보습력을 증가시키는 화장료의 연구개발이 활발해지고 있다.In order to solve this problem, we have recently developed natural-derived physiologically active materials from animals and plants to microorganisms and introduced them into cosmetics to maintain and improve the skin's own natural defense function, thereby suppressing moisture loss in the skin and increasing elasticity and moisturizing power. The R&D of cosmetic products is becoming active.
따라서, 본 연구에서는 현재 피부자극, 알러지, 염증유발을 억제하는 생리활성소재와 수분유지를 위한 안정적인 화장료 개발이 필수적이다.Therefore, in this study, it is essential to develop a bioactive material that suppresses skin irritation, allergy, and inflammation, and a stable cosmetic for moisture retention.
본 발명은 피부 수분량을 증진시키고, 표피층의 수분 손실을 억제하며, 피부자극, 알러지 및 트러블 등의 부작용을 일으키지 않고, 피부 보습력 증진과 항산화 활성 및 항염효과가 우수한 제형의 안정성도 크게 개선된 화장료 조성물을 제공하는데 있다.The present invention enhances skin moisture content, suppresses moisture loss in the epidermal layer, does not cause side effects such as skin irritation, allergies and troubles, and is a cosmetic composition with excellent skin moisturizing power, antioxidant activity and anti-inflammatory effect, and greatly improved stability of the formulation is to provide
전술한 본 발명의 과제는 1종 이상의 유화제 및 용매를 함유하는 리포좀 구성 물질, 및 봉입물질로서 락토바실러스발효물, 락토코커스발효물, 효모폴리펩타이드, 락토바실러스 아시도필루스 포도발효물을 함유하는 피부 보습 효과, 항산화 및 항염효과를 지닌 화장료 조성물을 제공함에 의해 달성된다.The above-described object of the present invention is a liposome constituent material containing one or more emulsifiers and solvents, and Lactobacillus fermented products, Lactococcus fermented products, yeast polypeptides, and Lactobacillus acidophilus grape fermented products as an encapsulation material. It is achieved by providing a cosmetic composition having a skin moisturizing effect, antioxidant and anti-inflammatory effect.
본 발명의 바람직한 특징에 따르면, 상기 락토바실러스발효물 90.0 내지 99.8 중량%, 상기 락토코커스발효물 0.01 내지 1.0 중량%, 상기 효모폴리펩타이드 0.01 내지 1.0 중량%, 상기 락토바실러스 아시도필루스 포도발효물 0.01 내지 2.0 중량%, 상기 레시틴 0.01 내지 2.0 중량%를 포함한다.According to a preferred feature of the present invention, 90.0 to 99.8 wt% of the Lactobacillus ferment, 0.01 to 1.0 wt% of the Lactococcus ferment, 0.01 to 1.0 wt% of the yeast polypeptide, and the Lactobacillus acidophilus grape fermentation 0.01 to 2.0% by weight, and 0.01 to 2.0% by weight of the lecithin.
본 발명의 바람직한 특징에 따르면, 상기 조성물의 제형은 유화형 자외선 차단용 크림, 유화형 파운데이션, 유화형 메이크업 베이스, 오일케익형 파운데이션, 투웨이케익, 또는 파우더 팩트 중 하나이다.According to a preferred feature of the present invention, the formulation of the composition is one of an emulsified sunscreen cream, an emulsified foundation, an emulsified makeup base, an oil cake-type foundation, a two-way cake, or a powder pact.
본 발명에 따른 락토바실러스발효물, 락토코커스발효물, 효모폴리펩타이드, 락토바실러스 아시도필루스 포도발효물을 안정화한 리포좀을 유효성분으로 함유하는 화장료 조성물은 피부 보습력과 표피층의 수분손실을 억제하며, 종래 사용되고 있는 보습 성분은 화학물로 구성되어 피부자극, 알러지, 독성 및 트러블 등의 부작용을 일으킬 수 있는 단점을 가지고 있는데 반해, 락토바실러스발효물, 락토코커스발효물, 효모폴리펩타이드, 락토바실러스 아시도필루스 포도발효물은 천연유래 생리활성물질로 피부 알러지, 트러블, 독성 등의 부작용을 일으키지 않으며, 우수한 피부 보습력과 수분유지효과를 제공하며, 항산화 및 항염 효과가 뛰어나 피부건조증이나 산화반응 및 염증반응을 개선하는 피부 보습제 및 기능성 화장료 또는 아토피 질환 개선용 화장료 및 치료제로 유용하게 이용할 수 있다.The cosmetic composition comprising, as an active ingredient, liposomes in which Lactobacillus fermented product, Lactococcus fermented product, yeast polypeptide, and Lactobacillus acidophilus grape fermented product according to the present invention are stabilized, inhibits skin moisturizing power and moisture loss in the epidermal layer, , conventionally used moisturizing ingredients are composed of chemicals and have disadvantages that can cause side effects such as skin irritation, allergies, toxicity, and troubles. Dophilus grape fermented product is a naturally-derived physiologically active substance that does not cause side effects such as skin allergies, troubles, and toxicity. It can be usefully used as a skin moisturizer and functional cosmetic for improving the reaction, or a cosmetic and therapeutic agent for improving atopic diseases.
도 1은 실시예 1 내지 4 및 비교예 1 내지 3의 세포증식율을 나타낸 그래프.
도 2는 실시예 5 및 비교예 4의 피부 보습 효과를 나타낸 그래프.
도 3은 실시예 5 및 비교예 4의 경피수분손실 개선효과를 나타낸 그래프.
도 4는 실시예 1 내지 4 및 비교예 1 내지 3의 자유라디칼 소거 효과를 나타낸 그래프.
도 5는 실시예 1 내지 4 및 비교예 1 내지 3의 지질과산화 억제효과를 나타낸 그래프.
도 6은 실시예 1 내지 4 및 비교예 1 내지 3의 리폭시게나아제 활성억제 효과를 나타낸 그래프.1 is a graph showing the cell proliferation rate of Examples 1 to 4 and Comparative Examples 1 to 3;
Figure 2 is a graph showing the skin moisturizing effect of Example 5 and Comparative Example 4.
Figure 3 is a graph showing the effect of improving the transdermal water loss of Example 5 and Comparative Example 4.
4 is a graph showing the free radical scavenging effect of Examples 1 to 4 and Comparative Examples 1 to 3;
5 is a graph showing the lipid peroxidation inhibitory effect of Examples 1 to 4 and Comparative Examples 1 to 3;
6 is a graph showing the lipoxygenase activity inhibitory effect of Examples 1 to 4 and Comparative Examples 1 to 3;
이하의 본 발명에 관한 상세한 설명들은 본 발명이 실시될 수 있는 실시 예이고 해당 실시 예의 예시로써 도시된 첨부 도면을 참조한다. 이들 실시 예는 당 업자가 본 발명의 실시에 충분하도록 상세히 설명된다. 본 발명의 다양한 실시 예는 서로 다르지만 상호 배타적일 필요는 없음이 이해되어야 한다. 예를 들어, 여기에 기재되어 있는 특정 형상, 구조 및 특성은 일 실시 예에 관련하여 본 발명의 사상 및 범위를 벗어나지 않으면서 다른 실시 예로 구현될 수 있다. 또한, 각각의 기재된 실시 예 내의 개별 구성요소의 위치 또는 배치는 본 발명의 사상 및 범위를 벗어나지 않으면서 변경될 수 있음이 이해되어야 한다.DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS The following detailed description of the present invention is an embodiment in which the present invention may be practiced, and reference is made to the accompanying drawings shown by way of example of the embodiment. These embodiments are described in sufficient detail to enable those skilled in the art to practice the present invention. It should be understood that various embodiments of the present invention are different but need not be mutually exclusive. For example, certain shapes, structures, and characteristics described herein may be implemented in other embodiments without departing from the spirit and scope of the invention in relation to one embodiment. In addition, it should be understood that the position or arrangement of individual components in each described embodiment may be changed without departing from the spirit and scope of the present invention.
따라서 후술되는 상세한 설명은 한정적인 의미로서 취하려는 것이 아니며, 본 발명의 범위는 적절하게 설명된다면 그 청구항들이 주장하는 것과 균등한 모든 범위와 더불어 첨부된 청구항에 의해서만 한정된다. 도면에서 유사한 참조부호는 여러 측면에 걸쳐서 동일하거나 유사한 기능을 지칭한다.Accordingly, the detailed description set forth below is not intended to be taken in a limiting sense, and the scope of the present invention, if properly described, is limited only by the appended claims, along with all scopes equivalent to those claimed by the claims. Like reference numerals in the drawings refer to the same or similar functions throughout the various aspects.
본 발명에서 사용되는 용어는 본 발명에서의 기능을 고려하면서 가능한 현재 널리 사용되는 일반적인 용어들을 선택하였으나, 이는 당 분야에 종사하는 기술자의 의도 또는 판례, 새로운 기술의 출현 등에 따라 달라질 수 있다. 또한, 특정한 경우는 출원인이 임의로 선정한 용어도 있으며, 이 경우 해당되는 발명의 설명 부분에서 상세히 그 의미를 기재할 것이다. 따라서 본 발명에서 사용되는 용어는 단순한 용어의 명칭이 아닌, 그 용어가 가지는 의미와 본 발명의 전반에 걸친 내용을 토대로 정의되어야 한다.The terms used in the present invention have been selected as currently widely used general terms as possible while considering the functions in the present invention, but these may vary depending on the intention or precedent of a person skilled in the art, the emergence of new technology, and the like. In addition, in a specific case, there is a term arbitrarily selected by the applicant, and in this case, the meaning will be described in detail in the description of the corresponding invention. Therefore, the term used in the present invention should be defined based on the meaning of the term and the overall content of the present invention, rather than the name of a simple term.
본 발명에서 어떤 부분이 어떤 구성요소를 “포함”한다고 할 때, 이는 특별히 반대되는 기재가 없는 한, 다른 구성요소를 제외하는 것이 아니라 다른 구성요소를 더 포함할 수 있음을 의미한다.In the present invention, when a part "includes" a certain component, it means that other components may be further included, rather than excluding other components, unless otherwise stated.
이하, 본 발명을 구체적인 실시예를 포함하여 자세히 설명한다.Hereinafter, the present invention will be described in detail including specific examples.
본 발명에 따른 락토바실러스발효물, 락토코쿠스발효물, 효모폴리펩타이드, 락토바실러스 아시도필루스 포도발효물을 유효성분으로 하는 화장료 조성물은 락토바실러스발효물, 락토코쿠스발효물, 효모폴리펩타이드, 락토바실러스 아시도필루스 포도발효물을 1종 이상의 계면활성제 및 식물성오일을 함유하는 리포좀으로 안정화하여 피부 보습, 피부 항산화 및 항염효과를 극대화하였다.The cosmetic composition comprising, as an active ingredient, a Lactobacillus fermented product, a lactococcus fermented product, a yeast polypeptide, and a Lactobacillus acidophilus grape fermented product according to the present invention is a Lactobacillus fermented product, a lactococcus fermented product, and a yeast polypeptide. , Lactobacillus acidophilus grape fermentation was stabilized with liposomes containing at least one surfactant and vegetable oil to maximize skin moisturizing, skin antioxidant and anti-inflammatory effects.
상기 락토바실러스발효물은 락토바실러스를 배양배지에 배양하여 발효시킨 후 멸균기로 멸균하고 0.1 ~ 0.3μm 사이즈의 필터로 분순물을 걸러내어 획득한 것을 지칭한다.The fermented Lactobacillus refers to a product obtained by culturing and fermenting Lactobacillus in a culture medium, sterilizing it with a sterilizer, and filtering impurities with a filter having a size of 0.1 to 0.3 μm.
상기 락토코쿠스발효물은 락토코쿠스를 배양 배지에 배양하여 발효시킨 후 멸균기로 멸균하고 0.1 ~ 0.3μm 사이즈의 필터로 분순물을 걸러내어 획득한 것을 지칭한다.The fermented lactococcus refers to a product obtained by culturing and fermenting lactococcus in a culture medium, sterilizing it with a sterilizer, and filtering impurities with a filter having a size of 0.1 to 0.3 μm.
상기 효모폴리펩타이드는 균주 발효물을 여과하여 얻은 여과물로부터 펩타이드를 분리한 것을 지칭하며, 더 자세하게는 사카로미세스 발효물을 여과하여 얻은 여과물로부터 펩타이드를 분리한 것이다. The yeast polypeptide refers to a separation of peptides from a filtrate obtained by filtration of a fermented strain, and more specifically, a separation of peptides from a filtrate obtained by filtration of a fermented Saccharomyces.
상기 락토바실러스 아시도필루스 포도발효물은 포도를 1:40의 비율로 50 ~ 70℃의 조건에서 4 ~ 8시간 추출하여 여과한 포도추출물에 락토바실러스 아시도필루스를 2%가 되게 접종하여 35 ~ 39℃의 조건에서 40 ~ 56시간 동안 발효한 발효물을 뜻한다.The Lactobacillus acidophilus grape fermented product is obtained by extracting grapes at a ratio of 1:40 at a temperature of 50 to 70° C. for 4 to 8 hours and inoculating the filtered grape extract with Lactobacillus acidophilus to 2%. It refers to a fermented product fermented for 40 to 56 hours at a temperature of 35 to 39°C.
상기 리포좀은 계면활성제와 식물성오일, 발효물을 포함하는 혼합물에 의해 제조되며, 1가 알코올을 포함하지 않는 것이 바람직하다.The liposome is prepared by a mixture containing a surfactant, vegetable oil, and fermented product, and preferably does not contain a monohydric alcohol.
상기 계면활성제는 레시틴, 라우릭애씨드, 라우릭글루코사이드, 데실글루코사이드, 코코글루코사이드, 소듐코코일 애플아미노산, 소듐코코일 글루타메이트, 포타슘코코일 글리시네이트 중 어느 하나 이상을 사용하는 것이 바람직하며, 가장 바람직하게는 레시틴을 사용하는 것이 적절할 것이다.The surfactant is preferably any one or more of lecithin, lauric acid, lauric glucoside, decyl glucoside, cocoglucoside, sodium cocoyl apple amino acid, sodium cocoyl glutamate, and potassium cocoyl glycinate, most preferably It would be appropriate to use lecithin.
상기 식물성오일은 식물로부터 추출된 오일을 뜻하며, 이에 사용될 수 있는 식물성오일로는 동백 오일(Camellia japonica seed oil), 유차 오일(Camellia oleifera seed oil), 코코넛 오일(Cocos nucifera oil), 피마자 오일(Ricinus communis seed oil), 카놀라 오일(Canola oil), 올리브 오일(Olea europaea fruit oil) 및 팜 오일(Elaeis guineensis oil)로 이루어지는 군으로부터 선택된 적어도 하나 이상의 식물성오일이 바람직할 것이다.The vegetable oil means an oil extracted from a plant, and vegetable oils that can be used therein include camellia oil (Camellia japonica seed oil), oleifera oil (Camellia oleifera seed oil), coconut oil (Cocos nucifera oil), castor oil (Ricinus) communis seed oil), canola oil (Canola oil), olive oil (Olea europaea fruit oil) and at least one vegetable oil selected from the group consisting of palm oil (Elaeis guineensis oil) will be preferred.
상기 리포좀은 구상의 리포좀 내부에 락토바실러스발효물, 락토코쿠스발효물, 효모폴리펩타이드, 락토바실러스 아시도필루스 포도발효물을 포집한 형태가 바람직할 것이다.The liposome will preferably have a form in which Lactobacillus fermented product, Lactococcus fermented product, yeast polypeptide, and Lactobacillus acidophilus grape fermented product are collected inside the spherical liposome.
본 발명의 일 실시예에 따른 화장료 조성물은 락토바실러스발효물, 락토코쿠스발효물, 효모폴리펩타이드, 락토바실러스 아시도필루스 포도발효물과 식물성오일 및 레시틴을 혼합한 리포좀형태의 기능성분을 포함한다.The cosmetic composition according to an embodiment of the present invention contains a functional ingredient in the form of a liposome in which Lactobacillus fermented product, Lactococcus fermented product, yeast polypeptide, Lactobacillus acidophilus grape fermented product, vegetable oil and lecithin are mixed. do.
본 발명의 일 실시예에 따른 화장료 조성물 중 식물성오일 및 레시틴의 함량이 각기 0.05 중량% 이하는 조성물 본 효과가 떨어지게 되며 5 중량% 이상은 제조된 제형의 사용감이 떨어지는 등 화장품으로써 사용이 힘든 점이 있기에 각기 0.05 내지 5 중량%의 양으로 첨가하는 것이 바람직하다.If the content of vegetable oil and lecithin in the cosmetic composition according to an embodiment of the present invention is less than 0.05% by weight, the main effect of the composition is deteriorated, and if it is 5% by weight or more, it is difficult to use as a cosmetic, such as the feeling of use of the prepared formulation decreases. It is preferable to add each in an amount of 0.05 to 5% by weight.
또한, 화장료 조성물 중 락토바실러스발효물, 락토코쿠스발효물, 효모폴리펩타이드, 락토바실러스 아시도필루스 포도발효물의 경우 기능성분을 지닌 발효물로 락토바실러스발효물 90 내지 99.6 중량%, 락토코쿠스발효물 0.01 내지 1.0 중량%, 효모폴리펩타이드 0.01 내지 1.0 중량%, 락토바실러스 아시도필루스 포도발효물 0.01 내지 1.0 중량%의 양으로 첨가하는 것이 바람직하다. In addition, in the case of Lactobacillus fermented product, Lactococcus fermented product, yeast polypeptide, and Lactobacillus acidophilus grape fermented product in the cosmetic composition, 90 to 99.6 wt% of Lactobacillus fermented product, Lactococcus, as a fermented product with functional ingredients It is preferable to add in an amount of 0.01 to 1.0% by weight of fermented product, 0.01 to 1.0% by weight of yeast polypeptide, and 0.01 to 1.0% by weight of fermentation of Lactobacillus acidophilus grapes.
본 발명의 일 실시예에 따른 화장료 조성물은 락토바실러스발효물, 락토코쿠스발효물, 효모폴리펩타이드, 락토바실러스 아시도필루스 포도발효물과 식물성오일 및 레시틴을 혼합한 리포좀형태의 유효성분을 포함한다.The cosmetic composition according to an embodiment of the present invention contains an active ingredient in the form of a liposome in which Lactobacillus fermented product, Lactococcus fermented product, yeast polypeptide, Lactobacillus acidophilus grape fermented product, vegetable oil and lecithin are mixed. do.
본 발명의 화장료 조성물에 포함되는 성분은 상기의 락토바실러스발효물, 락토코쿠스발효물, 효모폴리펩타이드, 락토바실러스 아시도필루스 포도발효물과 식물성오일 및 레시틴으로 안정화한 리포좀 이외에 화장료 조성물에 통상적으로 이용되는 성분들을 포함하며, 예컨대 항산화제, 안정화제, 용해화제, 비타민, 안료, 색소 및 향료와 같은 통상적인 보조제, 그리고 담체를 포함한다.The ingredients included in the cosmetic composition of the present invention are conventional in the cosmetic composition in addition to the above-mentioned Lactobacillus fermented product, Lactococcus fermented product, yeast polypeptide, Lactobacillus acidophilus grape fermented product and liposome stabilized with vegetable oil and lecithin. It includes components used as a pharmaceutical composition, for example, antioxidants, stabilizers, solubilizers, vitamins, pigments, and conventional adjuvants such as pigments and fragrances, and carriers.
본 발명의 화장료 조성물은 당 업계에서 통상적으로 제조되는 어떠한 제형으로도 제조될 수 있으며, 예를 들어, 용액, 현탁액, 유탁액, 페이스트, 겔, 크림, 로션, 파우더, 비누, 계면활성제-함유 클린싱, 오일, 분말 파운데이션, 유탁액 파운데이션, 왁스 파운데이션 및 스프레이 등으로 제형화 될 수 있으나, 이에 한정되는 것은 아니다. 보다 상세하게는, 유연 화장수, 영양 화장수, 영양크림, 맛사지 크림, 에센스, 팩, 아이 크림, 클렌징 크림, 클렌징 포옴, 클렌징 워터, 팩, 스프레이 또는 파우더의 제형으로 제조될 수 있다. 본 발명의 제형이 페이스트, 크림 또는 겔인 경우에는 담체 성분으로서 동물성유, 식물성유, 왁스, 파라핀, 전분, 트라칸트, 셀룰로오스 유도체, 폴리에틸렌글리콜, 실리콘, 벤토나이트, 실리카, 탈크 또는 산화아연 중 어느 하나 이상을 선택하여 이용될 수 있다.The cosmetic composition of the present invention may be prepared in any formulation conventionally prepared in the art, for example, a solution, suspension, emulsion, paste, gel, cream, lotion, powder, soap, surfactant-containing cleansing , oil, powder foundation, emulsion foundation, wax foundation, spray, etc., but is not limited thereto. More specifically, it may be prepared in the form of a flexible lotion, a nourishing lotion, a nourishing cream, a massage cream, an essence, a pack, an eye cream, a cleansing cream, a cleansing foam, a cleansing water, a pack, a spray, or a powder. When the formulation of the present invention is a paste, cream or gel, any one or more of animal oil, vegetable oil, wax, paraffin, starch, tracanth, cellulose derivative, polyethylene glycol, silicone, bentonite, silica, talc, or zinc oxide as a carrier component can be used by selecting .
본 발명의 제형이 파우더 또는 스프레이인 경우에는 담체 성분으로서 락토스, 탈크, 실리카, 알루미늄 히드록시드, 칼슘 실리케이트 또는 폴리아미드파우더가 이용될 수 있고, 특히 스프레이인 경우에는 추가적으로 클로로플루오로히드로카본, 프로판/부탄 또는 디메틸 에테르와 같은 추진체를 포함할 수 있다.When the formulation of the present invention is a powder or a spray, lactose, talc, silica, aluminum hydroxide, calcium silicate or polyamide powder may be used as a carrier component, and in particular, in the case of a spray, additional chlorofluorohydrocarbon, propane /may contain propellants such as butane or dimethyl ether.
본 발명의 제형이 용액 또는 유탁액인 경우에는 담체 성분으로서 용매, 용해화제 또는 유탁화제가 이용되고, 예컨대 물, 에탄올, 이소프로판올, 에틸카보네이트, 에틸 아세테이트, 벤질 알코올, 벤질 벤조에이트, 프로필렌글리콜, 부틸렌글리콜, 1,3-부틸글리콜 오일, 폴리옥시에칠렌 경화피마자유, 글리세롤, 글리세린, 지방족 에스테르, 페녹시에탄올, 트리에탄올아민, 폴리에틸렌 글리콜, 밀납, 폴리솔베이트 60, 솔비탄세스퀴오레이드, 파라핀, 소르비탄 스테아레이트, 친유형 모노스테아린산 글리세린, 스테아린산, 글리세릴스테아레이트/피이지-400 스테아레이트, 카르복시폴리머, 시토스테롤, 폴리글리세릴 2-올레이트, 세라마이드, 콜레스테롤, 스테아레스-4, 디세틸포스페이트, 마카다미아 오일, 카르복시비닐폴리머, 산탄검 또는 소르비탄의 지방산 에스테르 중 어느 하나 이상을 선택하여 이용될 수 있다.When the formulation of the present invention is a solution or emulsion, a solvent, solubilizer or emulsifier is used as a carrier component, for example, water, ethanol, isopropanol, ethyl carbonate, ethyl acetate, benzyl alcohol, benzyl benzoate, propylene glycol, butyl Renglycol, 1,3-butyl glycol oil, polyoxyethylene hydrogenated castor oil, glycerol, glycerin, aliphatic ester, phenoxyethanol, triethanolamine, polyethylene glycol, beeswax,
본 발명의 제형이 현탁액인 경우에는 담체 성분으로서 물, 에탄올, 글리세린, 부틸렌글리콜 또는 프로필렌 글리콜과 같은 액상의 희석제, 에톡실화 이소스테아릴 알코올, 폴리옥시에틸렌 소르비톨 에스테르 및 폴리옥시에틸렌 소르비탄 에스테르와 같은 현탁제, 미소결정성 셀룰로오스, 하이드록시에틸셀룰로오즈, 소디움히아루로네이트, 페녹시에탄올, 알루미늄 메타히드록시드, 벤토나이트, 스테아린산, 세틸알코올, 글리세릴모노스테아레이트, 폴리옥시에틸렌소르비탄모노스테아레이트, 솔비탄세스퀴올레이트, 글리세릴모노스테아레이트/글리세릴스테아레이트/폴리옥시에틸렌스테아레이트, 왁스, 파리핀, 스쿠알란, 카프릴릭/카프릭트리글리세라이드, 카르복시비닐폴리머, 트리에탄올아민, 아가 또는 트라칸트 중 어느 하나 이상을 선택하여 이용될 수 있다.When the formulation of the present invention is a suspension, as a carrier component, a liquid diluent such as water, ethanol, glycerin, butylene glycol or propylene glycol, ethoxylated isostearyl alcohol, polyoxyethylene sorbitol ester, and polyoxyethylene sorbitan ester; Suspending agents such as microcrystalline cellulose, hydroxyethyl cellulose, sodium hyaluronate, phenoxyethanol, aluminum metahydroxide, bentonite, stearic acid, cetyl alcohol, glyceryl monostearate, polyoxyethylene sorbitan monostearate , sorbitan sesquioleate, glyceryl monostearate/glyceryl stearate/polyoxyethylene stearate, wax, paraffin, squalane, caprylic/capric triglyceride, carboxyvinyl polymer, triethanolamine, agar or triglyceride Any one or more of Kant may be selected and used.
본 발명의 제형이 계면-활성제 함유 클린징인 경우에는 담체 성분으로서 지방족 알코올 설페이트, 지방족 알코올 에테르 설페이트, 설포숙신산 모노에스테르, 이세티오네이트, 이미다졸리늄 유도체, 메틸타우레이트, 사르코시네이트, 지방산 아미드 에테르 설페이트, 알킬아미도베타인, 지방족 알코올, 지방산 글리세리드, 지방산 디에탄올아미드, 식물성 유, 라놀린 유도체 또는 에톡실화 글리세롤 지방산 에스테르 중 어느 하나 이상을 선택하여 이용될 수 있다.When the formulation of the present invention is a surfactant-containing cleansing agent, aliphatic alcohol sulfate, aliphatic alcohol ether sulfate, sulfosuccinic acid monoester, isethionate, imidazolinium derivative, methyl taurate, sarcosinate, fatty acid amide as carrier components Any one or more of ether sulfate, alkylamidobetaine, fatty alcohol, fatty acid glyceride, fatty acid diethanolamide, vegetable oil, lanolin derivative, or ethoxylated glycerol fatty acid ester may be selected and used.
또한, 본 발명의 일 실시예에 따른 화장료 조성물의 사용효능은 개인의 피부상태와 컨디션, 외부 환경 조건에 따라 알맞게 조절이 가능하다.In addition, the use efficacy of the cosmetic composition according to an embodiment of the present invention can be appropriately adjusted according to an individual's skin condition and condition, and external environmental conditions.
이하, 본 발명의 이해를 돕기 위하여 바람직한 실시예 및 실험예를 제시한다. 그러나, 하기의 실시예 및 실험예는 본 발명을 보다 쉽게 이해하기 위하여 제공되는 것일 뿐, 이에 의해 본 발명의 기술적 수준과 범위가 한정되는 것은 아니다.Hereinafter, preferred examples and experimental examples are presented to help the understanding of the present invention. However, the following Examples and Experimental Examples are only provided for easier understanding of the present invention, and the technical level and scope of the present invention are not limited thereby.
< < 실시예Example 1-1 내지 1-4 및 1-1 to 1-4 and 비교예comparative example 1-1 내지 1-3 > 피부 보습 효과를 지닌 유효성분 조성물 제조 1-1 to 1-3 > Preparation of active ingredient composition with skin moisturizing effect
락토바실러스발효물과 락토코쿠스발효물은 적정 배양배지에 배양하여 발효 시킨 후 멸균기로 멸균하고 0.2μm 사이즈의 필터로 분순물을 걸러내어 획득하였으며, 효모폴리펩타이드는 사카로미세스 발효물을 여과하여 얻은 여과물로부터 펩타이드를 분리하였으며, 포도를 1:40의 비율로 60℃의 조건에서 6시간 추출하여 여과한 포도추출물에 락토바실러스 아시도필루스를 2%가 되게 접종하여 37℃의 조건에서 48시간 동안 발효하여 락토바실러스 아시도필루스 포도발효물을 확보하였다. 본 발명의 락토바실러스발효물, 락토코쿠스발효물, 효모폴리펩타이드, 락토바실러스 아시도필루스 포도발효물을 안정화한 리포좀을 함유하는 조성물(실시예), 리포좀 형태 아닌 상기 발효물은 표와 같이 락토바실러스발효물, 락토코쿠스발효물, 효모폴리펩타이드, 락토바실러스 아시도필루스 포도발효물을 혼합 비율별 조성물로 비교예 1-1 내지 1-3, 실시예 1-1 내지 1-4는 표 1과 같다.Fermented Lactobacillus and Lactococcus were cultured in an appropriate culture medium, fermented, sterilized with a sterilizer, and obtained by filtering impurities with a 0.2 μm filter. Yeast polypeptide was obtained by filtering Saccharomyces ferment Peptides were separated from the obtained filtrate, and grapes were extracted at a ratio of 1:40 at 60°C for 6 hours, and Lactobacillus acidophilus was inoculated to 2% of the filtered grape extract at 37°C for 48 hours. It was fermented for a period of time to obtain a fermentation product of Lactobacillus acidophilus grapes. Composition (Example) containing liposomes in which Lactobacillus fermented product, Lactococcus fermented product, yeast polypeptide, Lactobacillus acidophilus grape fermentation product of the present invention are stabilized (Example) Comparative Examples 1-1 to 1-3 and Examples 1-1 to 1-4 were prepared by mixing Lactobacillus fermented product, Lactococcus fermented product, yeast polypeptide, and Lactobacillus acidophilus grape fermented product by mixing ratio. Table 1 shows.
sample
< < 실시예Example 2 및 2 and 비교예comparative example 2> 본 발명의 조성물을 포함한 피부 보습을 지닌 2> With skin moisturizing including the composition of the present invention 화장료cosmetics 조성물의 제조 Preparation of the composition
아래 표 2의 화장료 조성비에 따라 락토바실러스발효물, 락토코쿠스발효물, 효모폴리펩타이드, 락토바실러스 아시도필루스 포도발효물을 식물성오일과 레시틴으로 안정화한 리포좀화 한 실시예 1-2를 함유하는 실시예 2의 화장료 및 락토바실러스발효물, 락토코쿠스발효물, 효모폴리펩타이드, 락토바실러스 아시도필루스 포도발효물을 리포좀화 하지 않은 비교예 1-2를 함유하는 비교예 2의 화장료 조성물을 제조하였다. According to the cosmetic composition ratio of Table 2 below, Lactobacillus fermented product, Lactococcus fermented product, yeast polypeptide, and Lactobacillus acidophilus grape fermented product were stabilized with vegetable oil and lecithin in Example 1-2 containing liposomes. Cosmetic composition of Comparative Example 2 containing the cosmetic of Example 2 and Comparative Example 1-2, which did not liposome the Lactobacillus fermented product, Lactococcus fermented product, yeast polypeptide, and Lactobacillus acidophilus grape fermented product was prepared.
(락토바실러스발효물/락토코쿠스발효물/효모폴리펩타이드/락토바실러스 아시도필루스 포도발효물)liposome
(Lactobacillus fermented product / Lactococcus fermented product / yeast polypeptide / Lactobacillus acidophilus grape fermented product)
(락토바실러스발효물/락토코쿠스발효물/효모폴리펩타이드/락토바실러스 아시도필루스 포도발효물liposome
(Lactobacillus fermented product / Lactococcus fermented product / yeast polypeptide / Lactobacillus acidophilus grape fermented product
비고
note
실시예 2
Example 2
비교예 2
Comparative Example 2
< 시험예 1 > 세포 무독성 및 세포증식 효과 평가<Test Example 1> Evaluation of cell nontoxicity and cell proliferation effect
상기 비교예 1-1 내지 1-3, 실시예 1-1 내지 1-4에서 제조된 시료에 대하여 세포배양을 이용한 세포 증식 효과를 측정하였다.The cell proliferation effect using cell culture was measured for the samples prepared in Comparative Examples 1-1 to 1-3 and Examples 1-1 to 1-4.
1) 실험방법1) Experimental method
세포 독성 및 증식 실험을 다음과 같은 방법으로 실시하였다. 배양하고 있는 세포(파이브로블라스트, 3T3 cell)를 96 웰 마이크로플레이트에 5,000세포/웰로 분주하여 30분간 항온조에서 배양하고, 시료를 농도별 각각 0.1, 0.5, 1, 5, 10 v/v%로 투여하여 72시간 동안 배양하였다. 그리고 티아졸린 블루(Thiazoline blue)를 투여하고 4시간 동안 추가 배양을 하였다. 배양액을 모두 버리고 마이크로플레이트의 각 웰에 반응 정지액을 가하고 5분간 교반한 후, 570nm에서 흡광도를 측정하였다. 대조군은 시료 주입량만큼 10% 우태아혈청(Fetal Bovine Serum, FBS)배지를 투여하여 세포 성장의 최적 조건으로 동시배양을 하였으며, 대조군의 세포증식을 100%로 하고 시료 투입 실험군의 세포 증식율을 계산하였다. Cytotoxicity and proliferation experiments were performed in the following way. Cells being cultured (fibroblast, 3T3 cells) were dispensed in a 96-well microplate at 5,000 cells/well and incubated in a thermostat for 30 minutes. It was administered and cultured for 72 hours. Then, thiazoline blue was administered and further incubated for 4 hours. After discarding all of the culture medium, a reaction stop solution was added to each well of the microplate, stirred for 5 minutes, and absorbance was measured at 570 nm. The control group was co-cultured under optimal conditions for cell growth by administering 10% Fetal Bovine Serum (FBS) medium as much as the sample injection amount. .
2) 실험결과2) Experiment result
세포증식 효과는 수학식 1에 의해 산출되었고, 그 결과는 하기 표 3에 나타내었다.The cell proliferation effect was calculated by
농도(v/v%)sample
Concentration (v/v%)
1-1comparative example
1-1
1-2comparative example
1-2
1-3comparative example
1-3
1-1Example
1-1
1-2Example
1-2
1-3Example
1-3
1-4Example
1-4
본 시험예 1은 락토바실러스발효물, 락토코커스발효물, 효모폴리펩타이드, 락토바실러스 아시도필루스 포도발효물을 식물성오일과 레시틴으로 안정화시킨 리포좀의 세포 독성 및 증식을 확인하기 위한 실험이었다. 표 3에 나타난 바와 같이, 세포 성장 최적 조건에서의 세포 증식을 100%로 하였을 때, 비교예 1-1 내지 1-3, 실시예 1-1 내지 1-4 모두 세포 증식효과가 있음을 확인하였다. This Test Example 1 was an experiment to confirm the cytotoxicity and proliferation of liposomes stabilized with Lactobacillus fermented product, Lactococcus fermented product, yeast polypeptide, and Lactobacillus acidophilus grape fermented product with vegetable oil and lecithin. As shown in Table 3, when the cell proliferation under the optimal cell growth conditions was 100%, it was confirmed that Comparative Examples 1-1 to 1-3 and Examples 1-1 to 1-4 all had a cell proliferation effect. .
또한, 세포 증식 효과가 있음은 락토바실러스발효물, 락토코커스발효물, 효모폴리펩타이드, 락토바실러스 아시도필루스 포도발효물을 식물성오일과 레시틴으로 안정화시킨 리포좀이 세포에 대한 독성이 없다는 것을 의미하는 것으로, 상기 세포 증식효과 실험으로부터 본 발명의 락토바실러스발효물, 락토코커스발효물, 효모폴리펩타이드, 락토바실러스 아시도필루스 포도발효물을 식물성오일과 레시틴으로 안정화시킨 리포좀이 우수한 세포증식 효과와 더불어 세포독성이 없는 안전한 것임을 확인할 수 있었다. In addition, the cell proliferation effect means that liposomes stabilized with Lactobacillus fermented product, Lactococcus fermented product, yeast polypeptide, and Lactobacillus acidophilus grape fermented product with vegetable oil and lecithin are not toxic to cells. As a result, from the cell proliferation effect experiment, liposomes stabilized with vegetable oil and lecithin in the Lactobacillus fermented product, Lactococcus fermented product, yeast polypeptide, and Lactobacillus acidophilus grape fermented product of the present invention with excellent cell proliferation effect and It was confirmed that it was safe without cytotoxicity.
그 중에서 실시예 1-2의 경우에는 실시예 1-1, 1-3, 1-4에 비하여 우수한 세포증식 효과가 있음을 확인하였다. Among them, in the case of Example 1-2, it was confirmed that there was an excellent cell proliferation effect compared to Examples 1-1, 1-3, and 1-4.
< < 시험예test example 2 > 피부 보습 개선효과 2 > Skin moisturizing effect
상기 실시예 1-2와 비교예 1-2의 화장료 조성물에 대하여 임상 보습 효과 및 지속력을 측정하였다.Clinical moisturizing effect and durability were measured for the cosmetic compositions of Examples 1-2 and Comparative Examples 1-2.
1) 실험방법1) Experimental method
피시험자(20세-45세의 남성 및 여성) 20명을 대상으로 1일 2회씩 4주간 안면 양쪽에 실시예 2 및 비교예 2의 크림을 각각 도포하여 도포하기 전, 2주 경과 후, 그리고 4주경과 후의 피부 보습 상태를 Corneometer CM 820 (Corage +Khazaka,Germany)를 이용하여 표피 수분량에 따른 전기전도도로 수치화하여 개선효과를 측정하였다.For 20 test subjects (males and females aged 20-45 years), twice a day for 4 weeks, each of the creams of Example 2 and Comparative Example 2 were applied on both sides of the face before application, after 2 weeks, and The improvement effect was measured by quantifying the skin moisture state after 4 weeks by using a Corneometer CM 820 (Corage + Khazaka, Germany) as an electrical conductivity according to the amount of moisture in the epidermis.
2) 실험결과2) Experiment result
피부 보습 개선에 관한 실험 결과는 하기 표 4에 나타내었다.The experimental results for skin moisturizing improvement are shown in Table 4 below.
표 4에 나타난 바와 같이 실시예 1-2와 비교예 1-2의 보습 효과를 비교한 결과 단순 리포좀 형태를 함유한 화장료보다 락토바실러스발효물/락토코쿠스발효물/효모폴리펩타이드/락토바실러스 아시도필루스 포도발효물을 함유한 실시예 1-2에서 시간이 경과될수록 피부 보습 효과가 우수해지는 것을 확인할 수 있었다. As shown in Table 4, as a result of comparing the moisturizing effect of Example 1-2 and Comparative Example 1-2, Lactobacillus fermented / Lactococcus fermented / Yeast polypeptide / Lactobacillus ash than cosmetics containing simple liposome form. In Example 1-2 containing Dophilus grape fermented product, it was confirmed that the skin moisturizing effect was improved as time passed.
< 시험예 3 > 경피수분손실량 평가<Test Example 3> Evaluation of transdermal water loss
상기 실시예 1-2와 비교예 1-2의 화장료 조성물에 대하여 경피수분손실량을 측정하였다.The amount of transdermal moisture loss was measured for the cosmetic compositions of Examples 1-2 and Comparative Examples 1-2.
1) 실험방법1) Experimental method
실시예 1-2 및 비교예 1-2의 크림을 각각 피시험자(20세-45세의 남성 및 여성) 20명을 대상으로 왼쪽 전완부의 시험부위인 6 부위에 일정량(2mg/cm2)의 크림을 도포한 후 잘 문지르고, TEWAMETER TM210(C+K eletronic GmhH. Germany)을 이용하여 경피수분손실량을 측정하였다. 도포하기 전 0시간의 수분 보유량을 기준으로 도포 후 30분, 도포 후 2시간, 4시간, 6시간 후의 수분증가율(%)을 측정하여 단기 보습 효과를 평가하였다. 측정시 probe를 수직으로 접촉하여 60초 동안 수평을 유지하면서 3회 연속적으로 경피수분손실량을 측정하였으며, 수치가 높을수록 수분의 손실이 많음을 의미한다. A certain amount (2mg/cm 2 ) of the cream of Examples 1-2 and Comparative Example 1-2 was applied to 20 test subjects (male and female aged 20-45 years), respectively, in 6 sites, the test site of the left forearm. After applying the cream, it was rubbed well, and the amount of transdermal water loss was measured using TEWAMETER TM210 (C+K eletronic GmhH. Germany). Short-term moisturizing effect was evaluated by measuring the moisture increase rate (%) 30 minutes after application, 2 hours, 4 hours, and 6 hours after application, based on the water retention amount of 0 hours before application. During the measurement, the amount of transdermal moisture loss was measured three times consecutively while keeping the probe horizontal for 60 seconds by touching the probe vertically.
2) 실험결과2) Experiment result
개선 효과는 수학식 2에 의해 산출되었고, 그 결과는 하기 표 5에 나타내었다.The improvement effect was calculated by Equation 2, and the results are shown in Table 5 below.
표 5에 나타난 바와 같이 실시예 1-2와 비교예 1-2의 경피수분손실량을 비교한 결과 실시예 1-2가 비교예 1-2보다 수분개선율이 월등히 높은 것을 확인하였다. 특히, 도포 후 30분이 경과되었을 시 실시예 1-2의 경우 도포전보다 33%가량 개선율이 증가되었으며 시간이 경과되면서 수분손실량이 발생되었지만 6시간까지 16.55%의 수분력을 유지하였다.As shown in Table 5, as a result of comparing the amount of transdermal moisture loss in Example 1-2 and Comparative Example 1-2, it was confirmed that Example 1-2 had a significantly higher moisture improvement rate than Comparative Example 1-2. In particular, when 30 minutes had elapsed after application, in Example 1-2, the improvement rate was increased by about 33% compared to before application.
반면 비교예 1-2의 경우 도포 후 30분 동안 15.49%의 개선율이 증가되었으나 2시간 경과 후 2.97%까지 개선율이 낮아지면서 4시간 후부터는 원래의 피부수분량으로 돌아오게 되었다. On the other hand, in Comparative Example 1-2, the improvement rate of 15.49% was increased for 30 minutes after application, but the improvement rate decreased to 2.97% after 2 hours, and returned to the original skin moisture content after 4 hours.
< 시험예 4 > 자유라디칼(free radical) 소거 효과 평가<Test Example 4> Free radical scavenging effect evaluation
상기 비교예 1-1 내지 1-3, 실시예 1-1 내지 1-4에서 제조된 시료에 대하여 자유라디칼(Free radical) 소거 효과를 측정하였다.The free radical scavenging effect was measured for the samples prepared in Comparative Examples 1-1 to 1-3 and Examples 1-1 to 1-4.
1)실험방법1) Experimental method
DPPH(1,1-디페닐-2피크릴-히드라질)법 (참조: Blois.M.S.Nature 181, 1190, 1958)을 사용하여 실험을 수행하였으며, DPPH와 Quercetin은 시그마(Sigma)사의 것을 사용하였다. 0.2 mM DPPH 메탄올 용액에 여러 농도(0.1, 0.5, 1, 5, 10 v/v%)의 비교예 1-1 내지 1-3, 실시예 1-1 내지 1-4의 시료를 에탄올 또는 메탄올 용액 2ml를 첨가하고 잘 교반한 후 실온에서 10분간 반응을 시킨다. 그리고 517nm에서 흡광도를 측정하였으며, 이때 공시험으로 각 시료 대신 정제수를 사용하였다. Experiments were performed using the DPPH (1,1-diphenyl-2 picryl-hydrazyl) method (see: Blois. MSNature 181, 1190, 1958), and DPPH and Quercetin were used by Sigma. . Samples of Comparative Examples 1-1 to 1-3 and Examples 1-1 to 1-4 of various concentrations (0.1, 0.5, 1, 5, 10 v/v%) in 0.2 mM DPPH methanol solution were mixed with ethanol or methanol solution 2ml is added, stirred well, and then reacted at room temperature for 10 minutes. And absorbance was measured at 517 nm, and purified water was used instead of each sample as a blank test.
2) 실험결과2) Experiment result
하기 수학식 3을 이용하여 자유라디칼 소거효과를 구하고 그 결과를 아래의 표 6에 기재하였다.The free radical scavenging effect was obtained using Equation 3 below, and the results are shown in Table 6 below.
농도(v/v%)sample
Concentration (v/v%)
1-1comparative example
1-1
1-2comparative example
1-2
1-3comparative example
1-3
1-1Example
1-1
1-2Example
1-2
1-3Example
1-3
1-4Example
1-4
상기 표 6에서 보는 바와 같이 비교예 1-1을 제외한 모든 시료에서 자유라디칼 소거효과가 우수한 것을 확인할 수 있었다. 비교예 1-2 및 1-3의 시료와 같이 락토바실러스발효물, 락토코쿠스발효물, 효모폴리펩타이드, 락토바실러스 아시도필루스 포도발효물의 혼합물로만 구성된 시료에서도 우수한 항산화 효과를 확인할 수 있었으나, 리포좀 형태의 실시예 1-1 내지 1-4의 시료 중에서 실시예 1-2의 자유라디칼 소거효과가 가장 우수한 것을 확인할 수 있었다. As shown in Table 6, it was confirmed that the free radical scavenging effect was excellent in all samples except Comparative Example 1-1. As with the samples of Comparative Examples 1-2 and 1-3, excellent antioxidant effects were also confirmed in samples composed only of a mixture of Lactobacillus fermented product, Lactococcus fermented product, yeast polypeptide, and Lactobacillus acidophilus grape fermented product, It was confirmed that the free radical scavenging effect of Example 1-2 was the most excellent among the samples of Examples 1-1 to 1-4 in the form of liposomes.
< 시험예 5 > 지질과산화(Lipid peroxydation) 억제 효과 평가<Test Example 5> Lipid peroxydation inhibitory effect evaluation
상기 비교예 1-1 내지 1-3, 실시예 1-1 내지 1-4에서 제조된 시료에 대하여 지질과산화(Lipid peroxydation) 억제 효과를 측정하였다. Lipid peroxydation inhibitory effect was measured for the samples prepared in Comparative Examples 1-1 to 1-3 and Examples 1-1 to 1-4.
1)실험방법1) Experimental method
8% Sodium lauryl sulfate 수용액에 linolenic acid를 0.1%가 되게 용해하여 3.9 ml을 취해서 여기에 농도별(0.1, 0.5, 1, 5, 10 v/v%)로 시료를 0.1ml를 첨가한 후 자외선을 한 시간 조사한다. 그리고 1ml를 취해서 0.8% TBA 수용액 1.5ml와 20% 초산(pH 3.5) 1.5ml를 첨가하고 1시간 동안 중탕하여 냉각한 후 정제수 1ml와 n-BuOH:Pyridine(15:1) 5ml를 가하여 진탕하고 원심분리 후 n-BuOH층을 취해 532nm에서 흡광도를 측정한다. Dissolve linolenic acid to 0.1% in 8% sodium lauryl sulfate aqueous solution, take 3.9 ml, add 0.1 ml of samples according to concentration (0.1, 0.5, 1, 5, 10 v/v%), and then irradiate with UV rays. Investigate for an hour Then, take 1 ml, add 1.5 ml of 0.8% TBA aqueous solution and 1.5 ml of 20% acetic acid (pH 3.5), cool in a bath for 1 hour, add 1 ml of purified water and 5 ml of n-BuOH:Pyridine (15:1), shake, and centrifuge. After separation, take the n-BuOH layer and measure the absorbance at 532 nm.
2) 실험결과2) Experiment result
공시험은 시료를 첨가하지 않은 것으로 하였다. 하기 수학식 4를 이용하여 지질과산화 효과를 구하고 그 결과를 아래의 표 7에 기재하였다.In the blank test, no sample was added. The effect of lipid peroxidation was calculated using Equation 4 below, and the results are shown in Table 7 below.
농도(v/v%)sample
Concentration (v/v%)
1-1comparative example
1-1
1-2comparative example
1-2
1-3comparative example
1-3
1-1Example
1-1
1-2Example
1-2
1-3Example
1-3
1-4Example
1-4
상기 표 7에서 보는 바와 같이 비교예 1-1을 제외한 모든 시료에서 지질과산화 억제율이 우수한 것을 확인할 수 있었다. 비교예 1-2 및 1-3의 시료와 같이 락토바실러스발효물, 락토코쿠스발효물, 효모폴리펩타이드, 락토바실러스 아시도필루스 포도발효물의 혼합물로만 구성된 시료에서도 우수한 지질과산화 억제율을 확인할 수 있었으며, 리포좀 형태의 실시예 1-1 내지 1-4의 중 실시예 1-2의 지질과산화 억제율이 가장 우수한 것을 확인할 수 있었다. As shown in Table 7, it was confirmed that the lipid peroxidation inhibition rate was excellent in all samples except Comparative Example 1-1. As with the samples of Comparative Examples 1-2 and 1-3, excellent lipid peroxidation inhibition rates were confirmed in samples composed only of a mixture of Lactobacillus fermented product, Lactococcus fermented product, yeast polypeptide, and Lactobacillus acidophilus grape fermented product. , It was confirmed that the lipid peroxidation inhibition rate of Example 1-2 among Examples 1-1 to 1-4 in the form of liposomes was the best.
< 시험예 6 > 리폭시게나아제(Lpoxygenase) 활성억제 효과 평가<Test Example 6> Lipoxygenase (Lpoxygenase) activity inhibitory effect evaluation
상기 비교예 1-1 내지 1-3, 실시예 1-1 내지 1-4에서 제조된 시료에 대하여 리폭시게나아제(Lipoxygenase) 활성억제 효과를 측정하였다. The lipoxygenase activity inhibitory effect was measured for the samples prepared in Comparative Examples 1-1 to 1-3 and Examples 1-1 to 1-4.
1)실험방법1) Experimental method
TBAS법을 사용하여 실험을 수행하였으며, 실험에 사용하는 Linoleic acid와 Lipoxygenase, Thiobabitulic acid, Quercetin는 시그마(SIGMA)사의 것을 사용하였다. 1mM Linoleic acid 1ml에 여러 농도(0.1, 0.5, 1, 5, 10 v/v%)의 비교예 1-1 내지 1-3, 실시예 1-1 내지 1-4를 0.05ml를 첨가하고 Lipoxygenase 0.95ml를 투여 후 잘 교반하고 25℃에서 10분간 반응을 시킨다. 그리고 Trichloroacetic acid를 0.5ml 투여하고 Thiobarbiturlic acid 1ml 첨가한 후 10분간 heating을 한 후 얼음물에서 2 ~ 3분간 냉각시켜 반응을 종료시킨다. 반응이 종결된 반응액에 Butanol 2ml를 넣고 4,000 ⅹ g로 5분간 원심분리한 후 535nm에서 흡광도를 측정하였으며, 이때 공시험으로 각 시료 대신 정제수를 사용하였다.The experiment was performed using the TBAS method, and those of Sigma (SIGMA) were used for Linoleic acid, Lipoxygenase, Thiobabitulic acid, and Quercetin used in the experiment. To 1 ml of 1 mM Linoleic acid, 0.05 ml of Comparative Examples 1-1 to 1-3 and Examples 1-1 to 1-4 of various concentrations (0.1, 0.5, 1, 5, 10 v/v%) were added, and lipoxygenase 0.95 After administration of ml, the mixture is stirred well and allowed to react at 25°C for 10 minutes. Then, 0.5 ml of trichloroacetic acid was administered, 1 ml of thiobarbiturlic acid was added, and after heating for 10 minutes, the reaction was terminated by cooling in ice water for 2 to 3 minutes. After completion of the reaction, 2 ml of Butanol was added to the reaction solution, centrifuged at 4,000 x g for 5 minutes, and absorbance was measured at 535 nm. In this case, purified water was used instead of each sample as a blank test.
2) 실험결과2) Experiment result
하기 수학식 5를 이용하여 리폭시게나아제 활성억제 효과를 구하고 그 결과를 아래의 표 8에 기재하였다.The lipoxygenase activity inhibitory effect was obtained using
농도(v/v%)sample
Concentration (v/v%)
1-1comparative example
1-1
1-2comparative example
1-2
1-3comparative example
1-3
1-1Example
1-1
1-2Example
1-2
1-3Example
1-3
1-4Example
1-4
상기 표 8에서 보는 바와 같이 비교예 1-1을 제외한 모든 시료에서 리폭시게나아제 활성 억제율이 우수한 것을 확인할 수 있었다. 비교예 1-2 및 1-3의 시료와 같이 락토바실러스발효물, 락토코쿠스발효물, 효모폴리펩타이드, 락토바실러스 아시도필루스 포도발효물의 혼합물로만 구성된 시료에서도 우수한 억제율을 확인할 수 있었으며, 리포좀 형태의 실시예 1-1 내지 1-4의 중 실시예 1-2의 리폭시게나아제 활성 억제율이 가장 우수한 것을 확인할 수 있었다.As shown in Table 8, it was confirmed that the lipoxygenase activity inhibition rate was excellent in all samples except Comparative Example 1-1. As with the samples of Comparative Examples 1-2 and 1-3, excellent inhibition was confirmed even in a sample composed only of a mixture of Lactobacillus fermented product, Lactococcus fermented product, yeast polypeptide, and Lactobacillus acidophilus grape fermented product, and liposomes Of the forms of Examples 1-1 to 1-4, it was confirmed that the lipoxygenase activity inhibition rate of Example 1-2 was the most excellent.
따라서, 본 발명의 식물성오일과 레시틴으로 안정화시킨 리포좀에 락토바실러스발효물, 락토코커스발효물, 효모폴리펩타이드, 락토바실러스 아시도필루스 포도발효물을 유효성분으로 봉입하여 이것을 포함한 화장료 조성물은 피부 보습, 항산화 및 항염효과가 우수하여 화장료 조성물로 유용함을 알 수 있다.Therefore, the Lactobacillus fermented product, Lactococcus fermented product, yeast polypeptide, and Lactobacillus acidophilus grape fermented product are encapsulated as active ingredients in the liposome stabilized with vegetable oil and lecithin of the present invention. , it can be seen that it is useful as a cosmetic composition due to its excellent antioxidant and anti-inflammatory effects.
이하, 상기한 실험예들의 결과를 근거로 하여 식물성오일과 레시틴으로 안정화시킨 리포좀에 락토바실러스발효물, 락토코커스발효물, 효모폴리펩타이드, 락토바실러스 아시도필루스 포도발효물을 유효성분으로 봉입한 혼합물을 함유하는 화장료를 조성하여 하기와 같이 제시한다. 그러나 본 발명의 조성물이 하기의 제형예에 한하여 제한되는 것은 아니다.Hereinafter, based on the results of the above experimental examples, Lactobacillus fermented products, Lactococcus fermented products, yeast polypeptides, and Lactobacillus acidophilus grape fermented products were encapsulated as active ingredients in liposomes stabilized with vegetable oil and lecithin. A cosmetic composition containing the mixture is formulated and presented as follows. However, the composition of the present invention is not limited to the following formulation examples.
< 제형예 1 > 본 발명에 따른 피부 보습, 항산화, 항염 효과를 가지는 식물성오일과 레시틴으로 안정화시킨 리포좀에 락토바실러스발효물 , 락토코커스발효물 , 효모폴리펩타이드 , 락토바실러스 아시도필루스 포도발효물을 함유하는 화장수의 제조 < Formulation Example 1> In liposomes stabilized with vegetable oil and lecithin having skin moisturizing, antioxidant, and anti-inflammatory effects according to the present invention Lactobacillus ferment , Lactococcus ferment , Yeast polypeptide , Lactobacillus acidophilus Preparation of lotion containing fermented grapes
락토바실러스발효물/락토코쿠스발효물/효모폴리펩타이드/락토바실러스 아시도필루스 포도발효물을 식물성오일과 레시틴으로 안정화한 리포좀을 함유한 화장료 중 화장수(스킨로션)의 처방예는 표 9과 같다.Table 9 shows the formulation examples of lotion (skin lotion) among cosmetics containing liposomes stabilized with lactobacillus fermented product / lactococcus fermented product / yeast polypeptide / lactobacillus acidophilus grape fermented product with vegetable oil and lecithin same.
/락토바실러스 아시도필루스 포도발효물)Liposome (Lactobacillus ferment / Lactococcus ferment / yeast polypeptide
/Lactobacillus acidophilus grape fermentation)
5.0
<제조방법><Production method>
11번에 2, 3, 4, 8번을 순서대로 투입하고 교반하여 용해시킨 후, 5번을 60℃ 정도 가열하여 용해시킨 후, 10번을 투입하여 용해한 후 11번에 투입한다. 마지막으로 6, 7, 9번을 투입한 뒤 1을 투입하여 충분히 교반한 뒤 숙성시킨다.After putting No. 2, 3, 4, and 8 into No. 11 in order and stirring to dissolve, No. 5 is heated to about 60° C. to dissolve, No. 10 is put in to dissolve, and then No. 11 is added. Finally, after adding Nos. 6, 7, and 9, add 1, stir sufficiently, and then ripen.
< 제형예 2 > 본 발명에 따른 피부 보습, 항산화, 항염 효과를 가지는 식물성오일과 레시틴으로 안정화시킨 리포좀에 락토바실러스발효물 , 락토코커스발효물 , 효모폴리펩타이드, 락토바실러스 아시도필루스 포도발효물을 함유하는 영양로션의 제조 < Formulation Example 2> In liposomes stabilized with vegetable oil and lecithin having skin moisturizing, antioxidant, and anti-inflammatory effects according to the present invention Lactobacillus ferment , Lactococcus ferment , Yeast polypeptide, Lactobacillus acidophilus Preparation of nutritional lotion containing fermented grapes
락토바실러스발효물/락토코쿠스발효물/효모폴리펩타이드/락토바실러스 아시도필루스 포도발효물을 식물성오일과 레시틴으로 안정화한 리포좀을 함유한 화장료 중 영양로션의 처방예는 표 10과 같다.Table 10 shows a prescription example of a nutritional lotion among cosmetics containing liposomes in which Lactobacillus fermented product / Lactococcus fermented product / yeast polypeptide / Lactobacillus acidophilus grape fermented product is stabilized with vegetable oil and lecithin.
/락토바실러스 아시도필루스 포도발효물)Liposome (Lactobacillus ferment / Lactococcus ferment / yeast polypeptide
/Lactobacillus acidophilus grape fermentation)
<제조방법><Production method>
10, 11, 13, 16을 혼합 교반하면서 80 ~ 85℃ 사이로 가열하여 제조부에 투입한 후 유화기를 작용시키고 2, 3, 4, 5, 6, 7, 8, 9, 12를 80 ~ 85℃ 사이로 가열 용해한 후 유화한다. 유화가 끝나면 교반기를 이용하여 교반하면서 50℃까지 냉각한 뒤 15번을 투입하고 45℃까지 냉각한 뒤 14번을 투입하고 35℃에 1번을 투입하여 25℃까지 냉각한 뒤 숙성시킨다.10, 11, 13, 16 are mixed and stirred at 80 ~ 85 ℃ and heated to 80 ~ 85 ℃, put into the manufacturing unit, and then the emulsifier works, and 2, 3, 4, 5, 6, 7, 8, 9, 12 is heated to 80 ~ 85 ℃ Emulsify after dissolving by heating. After the emulsification is finished, use a stirrer to cool to 50°C, add No. 15, cool to 45°C, add No. 14, put No. 1 at 35°C, cool to 25°C, and then ripen.
< 제형예 3 > 본 발명에 따른 피부 보습, 항산화, 항염 효과를 가지는 식물성오일과 레시틴으로 안정화시킨 리포좀에 락토바실러스발효물 , 락토코커스발효물 , 효모폴리펩타이드, 락토바실러스 아시도필루스 포도발효물을 함유하는 영양크림의 제조 < Formulation Example 3> In liposomes stabilized with vegetable oil and lecithin having skin moisturizing, antioxidant, and anti-inflammatory effects according to the present invention Lactobacillus ferment , Lactococcus ferment , Yeast polypeptide, Lactobacillus acidophilus Preparation of nutritional cream containing fermented grapes
락토바실러스발효물/락토코쿠스발효물/효모폴리펩타이드/락토바실러스 아시도필루스 포도발효물을 식물성오일과 레시틴으로 안정화한 리포좀을 함유한 화장료 중 영양크림의 처방예는 표 11과 같다.Table 11 shows a prescription example of a nutritional cream among cosmetics containing liposomes in which Lactobacillus fermented product / Lactococcus fermented product / yeast polypeptide / Lactobacillus acidophilus grape fermented product is stabilized with vegetable oil and lecithin.
/락토바실러스 아시도필루스 포도발효물)Liposome (Lactobacillus ferment / Lactococcus ferment / yeast polypeptide
/Lactobacillus acidophilus grape fermentation)
<제조방법><Production method>
12, 13, 14, 16을 혼합 교반하면서 80 ~ 85℃ 사이로 가열하여 제조부에 투입한 후 유화기를 작용시키고 2, 3, 4, 5, 6, 7, 8, 9, 10, 11을 80 ~ 85℃ 사이로 가열하여 용해한 후 15를 투입 교반하여 제조부에 투입하고 유화한다. 유화가 끝나면 교반기를 이용하여 교반하면서 35℃까지 냉각하고 1번을 투입하여 25℃까지 냉각한 뒤 숙성시킨다.12, 13, 14, and 16 are mixed and stirred, heated to 80 ~ 85 ℃, put into the manufacturing unit, and then the emulsifier works, and 2, 3, 4, 5, 6, 7, 8, 9, 10, 11 are heated to 80 ~ After dissolution by heating to between 85 °C, 15 is added and stirred to put into the manufacturing unit and emulsify. When the emulsification is finished, it is cooled to 35°C while stirring using a stirrer, and then cooled to 25°C by adding No. 1 and then aged.
< 제형예 4 > 본 발명에 따른 피부 보습, 항산화, 항염 효과를 가지는 식물성오일과 레시틴으로 안정화시킨 리포좀에 락토바실러스발효물 , 락토코커스발효물 , 효모폴리펩타이드, 락토바실러스 아시도필루스 포도발효물을 함유하는 에센스의 제조 < Formulation Example 4> In liposomes stabilized with vegetable oil and lecithin having skin moisturizing, antioxidant, and anti-inflammatory effects according to the present invention Lactobacillus ferment , Lactococcus ferment , Yeast polypeptide, Lactobacillus acidophilus Preparation of Essence Containing Grape Fermentation
락토바실러스발효물/락토코쿠스발효물/효모폴리펩타이드/락토바실러스 아시도필루스 포도발효물을 식물성오일과 레시틴으로 안정화한 리포좀을 함유한 화장료 중 에센스의 처방예는 표 12와 같다.Table 12 shows the formulation examples of essences in cosmetics containing liposomes stabilized by lactobacillus fermented product/lactococcus fermented product/yeast polypeptide/lactobacillus acidophilus grape fermented product with vegetable oil and lecithin.
/락토바실러스 아시도필루스 포도발효물)Liposome (Lactobacillus ferment / Lactococcus ferment / yeast polypeptide
/Lactobacillus acidophilus grape fermentation)
<제조방법><Production method>
2, 3, 4, 5 및 6을 일정한 온도에서 균질화하여 비이온계 양친매성 지질이라 칭한다. 상기 비이온계 양친매성 지질과 7, 8 및 14를 혼합한 후, 1번을 투입하여 혼합하고 일정한 온도에서 균질화하여 마이크로플루이다이져를 통과하고 이어 9를 일정한 온도에서 서서히 첨가하여 균질화한 후 다시 마이크로플루이다이져에 재차 통과시킨다 그리고 10, 11, 12, 13을 투입하여 분산시켜 안정화하고 숙성시킨다.2, 3, 4, 5 and 6 are homogenized at a constant temperature and are referred to as nonionic amphiphilic lipids. After mixing the nonionic amphiphilic lipids 7, 8, and 14, add No. 1 to mix, homogenize at a constant temperature, pass through a microfluidizer, and then slowly add 9 at a constant temperature to homogenize and then again Pass it through a microfluidizer again, and add 10, 11, 12, and 13 to disperse, stabilize and mature.
본 발명을 첨부된 도면과 함께 설명하였으나, 이는 본 발명의 요지를 포함하는 다양한 실시 형태 중의 하나의 실시 예에 불과하며, 당 업계에서 통상의 지식을 가진 자가 용이하게 실시할 수 있도록 하는 데에 그 목적이 있는 것으로, 본 발명은 상기 설명된 실시예에만 국한되는 것이 아님은 명확하다. 따라서, 본 발명의 보호범위는 하기의 청구범위에 의해 해석되어야 하며, 본 발명의 요지를 벗어나지 않는 범위 내에서 변경, 치환, 대체 등에 의해 그와 동등한 범위 내에 있는 모든 기술사상은 본 발명의 권리에 포함될 것이다. 또한, 도면의 일부 구성은 구성을 보다 명확하게 설명하기 위한 것으로 실제보다 과장되거나 축소되어 제공되는 것임을 명확히 한다.Although the present invention has been described with the accompanying drawings, this is only one embodiment of various embodiments including the gist of the present invention, and is intended to be easily implemented by those of ordinary skill in the art. For the purpose, it is clear that the present invention is not limited to the embodiments described above. Therefore, the protection scope of the present invention should be interpreted by the following claims, and all technical ideas within the scope equivalent to that by changes, substitutions, substitutions, etc. within the scope not departing from the gist of the present invention are in the right of the present invention. will be included In addition, it is clarified that some components of the drawings are provided in an exaggerated or reduced form than in reality for more clearly explaining the configuration.
Claims (8)
봉입물질로서 락토바실러스발효물, 락토코커스발효물, 효모폴리펩타이드, 락토바실러스 아시도필루스 포도발효물을 함유하여 리포좀을 형성하되,
상기 락토바실러스발효물, 락토코커스발효물, 효모폴리펩타이드, 락토바실러스 아시도필루스 포도발효물, 계면활성제 및 식물성오일이 99.6 : 0.1 : 0.1 : 0.1 : 0.05 : 0.05의 중량비로 이루어져 피부 보습 효과, 피부 항산화 효과 및 피부 항염 효과를 갖는 것을 특징으로 하는 락토바실러스발효물, 락토코쿠스발효물, 효모폴리펩타이드, 락토바실러스 아시도필루스 포도발효물을 유효성분으로 하는 화장료 조성물.
Liposome constituent material containing at least one surfactant and vegetable oil, and
Forming liposomes by containing Lactobacillus fermented product, Lactococcus fermented product, yeast polypeptide, and Lactobacillus acidophilus grape fermented product as an encapsulation material,
The Lactobacillus fermented product, Lactococcus fermented product, yeast polypeptide, Lactobacillus acidophilus grape fermented product, surfactant and vegetable oil are in a weight ratio of 99.6: 0.1: 0.1: 0.1: 0.05: 0.05 to provide a skin moisturizing effect, A cosmetic composition comprising, as an active ingredient, a lactobacillus fermented product, a lactococcus fermented product, a yeast polypeptide, and a lactobacillus acidophilus grape fermented product, characterized in that it has a skin antioxidant effect and an anti-inflammatory effect on the skin.
상기 리포좀은 계면활성제, 식물성오일 및 발효물을 포함하는 혼합물에 의해 제조되며, 1가 알코올을 포함하지 않는 것을 특징으로 하는 락토바실러스발효물, 락토코쿠스발효물, 효모폴리펩타이드, 락토바실러스 아시도필루스 포도발효물을 유효성분으로 하는 화장료 조성물.
According to claim 1,
The liposome is prepared by a mixture containing a surfactant, vegetable oil and fermented product, and Lactobacillus fermented product, lactococcus fermented product, yeast polypeptide, Lactobacillus acido, characterized in that it does not contain a monohydric alcohol A cosmetic composition comprising fermented phyllus grapes as an active ingredient.
상기 계면활성제는 레시틴을 포함하는 것을 특징으로 하는 락토바실러스발효물, 락토코쿠스발효물, 효모폴리펩타이드, 락토바실러스 아시도필루스 포도발효물을 유효성분으로 하는 화장료 조성물.
According to claim 1,
The surfactant is Lactobacillus fermented product, lactococcus fermented product, yeast polypeptide, Lactobacillus acidophilus grape fermented product as an active ingredient, characterized in that it contains lecithin.
상기 화장료 조성물은 화장수, 스킨, 로션, 크림, 파운데이션, 에센스, 젤, 팩, 유화형 자외선 차단용 크림, 유화형 파운데이션, 유화형 메이크업 베이스, 오일케익형 파운데이션, 투웨이케익, 또는 파우더 팩트의 제형으로 제형화하는 것을 특징으로 하는 락토바실러스발효물, 락토코쿠스발효물, 효모폴리펩타이드, 락토바실러스 아시도필루스 포도발효물을 유효성분으로 하는 화장료 조성물.
According to claim 1,
The cosmetic composition is in the form of a lotion, skin, lotion, cream, foundation, essence, gel, pack, emulsified sunscreen cream, emulsified foundation, emulsified makeup base, oil cake-type foundation, two-way cake, or powder pact. A cosmetic composition comprising, as an active ingredient, a Lactobacillus fermented product, a lactococcus fermented product, a yeast polypeptide, and a Lactobacillus acidophilus grape fermented product, characterized in that it is formulated.
리포좀으로 안정화한 락토바실러스발효물, 락토코커스발효물, 효모폴리펩타이드 및 락토바실러스 아시도필루스 포도발효물이 조성물 총중량에 대해서 0.01 내지 10 중량%의 함유된 것을 특징으로 하는 락토바실러스발효물, 락토코쿠스발효물, 효모폴리펩타이드, 락토바실러스 아시도필루스 포도발효물을 유효성분으로 하는 화장료 조성물.
8. The method of claim 7,
Lactobacillus fermented product, lactobacilli, characterized in that the liposome-stabilized Lactobacillus ferment, Lactococcus ferment, yeast polypeptide, and Lactobacillus acidophilus grape fermented product are contained in an amount of 0.01 to 10% by weight based on the total weight of the composition. A cosmetic composition comprising, as an active ingredient, a couscous fermented product, a yeast polypeptide, and a Lactobacillus acidophilus grape fermented product.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020190061929A KR102283326B1 (en) | 2019-05-27 | 2019-05-27 | Cosmetic compositions containing Fermented products of Lactobacillus, Fermented products of Lactococcus, Sacchromyces peptide, Lactobacillus acidophilus/grape ferment |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020190061929A KR102283326B1 (en) | 2019-05-27 | 2019-05-27 | Cosmetic compositions containing Fermented products of Lactobacillus, Fermented products of Lactococcus, Sacchromyces peptide, Lactobacillus acidophilus/grape ferment |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20200136194A KR20200136194A (en) | 2020-12-07 |
KR102283326B1 true KR102283326B1 (en) | 2021-07-29 |
Family
ID=73791388
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020190061929A Active KR102283326B1 (en) | 2019-05-27 | 2019-05-27 | Cosmetic compositions containing Fermented products of Lactobacillus, Fermented products of Lactococcus, Sacchromyces peptide, Lactobacillus acidophilus/grape ferment |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR102283326B1 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113576943B (en) * | 2021-07-09 | 2022-07-12 | 中山大学 | A kind of prebiotic fermentation product and its preparation method and application |
CN118319829B (en) * | 2024-04-18 | 2025-03-28 | 雅致优品(广东)智能生物科技有限公司 | A skin care composition containing lactobacillus/algae extract fermentation product and its preparation method and application |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2005513076A (en) * | 2001-12-20 | 2005-05-12 | テクノロジーズ バイオラクティス インコーポレイティド | Malleable protein matrix and uses thereof |
KR101642054B1 (en) * | 2016-02-29 | 2016-07-22 | 주식회사 매그니프 | Composition for transdermal transfer and cosmetics containing the same |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20130085012A (en) * | 2012-01-18 | 2013-07-26 | 주식회사 엘지생활건강 | Cosmetic composition comprising fermented material and manufacturing method thereof |
KR102147764B1 (en) * | 2014-03-03 | 2020-08-26 | 김윤규 | Spingoliposome cosmetic composition with effect of proliferation of skin cells |
-
2019
- 2019-05-27 KR KR1020190061929A patent/KR102283326B1/en active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2005513076A (en) * | 2001-12-20 | 2005-05-12 | テクノロジーズ バイオラクティス インコーポレイティド | Malleable protein matrix and uses thereof |
KR101642054B1 (en) * | 2016-02-29 | 2016-07-22 | 주식회사 매그니프 | Composition for transdermal transfer and cosmetics containing the same |
Also Published As
Publication number | Publication date |
---|---|
KR20200136194A (en) | 2020-12-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2020024703A1 (en) | Water-soluble fullerene topical composition | |
CN1761450B (en) | Skin external preparation characterized by containing saccharide derivative of alpha, alpha-trehalose | |
KR101912478B1 (en) | Exopolysaccharide for the treatment and/or care of the skin, mucous membranes, hair and/or nails | |
KR102217663B1 (en) | Cosmetic Composition For Skin Moisturizing Containing Mixture of Malva Sylvestris (Mallow) Extract, Aloe Barbadensis Leaf Extract, Dioscorea Japonica Root Extract And Hibiscus Esculentus Fruit Extract | |
JPWO2004016236A1 (en) | Cosmetics | |
KR102142311B1 (en) | Skin external composition comprising tangeretin | |
KR20120054906A (en) | Solubilization cosmetic composition containing oleanolic acid | |
KR102667625B1 (en) | Cosmetic composition for improving skin barrier and skin moisturing and method for maufacturing thereof | |
KR102283326B1 (en) | Cosmetic compositions containing Fermented products of Lactobacillus, Fermented products of Lactococcus, Sacchromyces peptide, Lactobacillus acidophilus/grape ferment | |
KR102022230B1 (en) | Structure of emulsions for enhancing the skin penetration and method of producing the same | |
KR20190021083A (en) | Cosmetic composition comprising extract of Alpinia officinarum Hance as active ingredient | |
CN117653561A (en) | Anti-aging active composition, application thereof and anti-aging essential oil | |
KR20090009054A (en) | Cosmetic composition containing nanovegetal vitatox having antioxidant effect and wrinkle improvement | |
KR102100820B1 (en) | Rosa centifolia flower petal fermented by aureobasidium pullulans | |
JP2005213187A (en) | Involucrin production promoter | |
KR20220001161A (en) | Composition for skin protection, including extracts derived from natural products | |
KR100858628B1 (en) | Cosmetic composition for skin stimulation alleviation comprising soruja extract stabilized with nano liposomes | |
KR101620820B1 (en) | A cosmetic composition for skin appearance improvement comprising ginsenoside Rh2 as an active ingredient | |
KR100532633B1 (en) | Cosmetic composition having anti-inflammatory, skin-protecting, skin-elastic effects which comprise mixed plants extract | |
KR101557422B1 (en) | Cleansing composition and cosmetic composition with the extract of Styrax japonica | |
KR102333132B1 (en) | Cosmetic Composition containing Frangipani Oil or Fermented Frangipani Oil | |
KR20230095381A (en) | Cosmetic composition comprising Actinidia fruit extract, actinidia flower extract and actinidia stem extract, and method for manufacturing the same | |
KR102334348B1 (en) | Cosmetic Composition For Moisturizing Skin Comprising Mixed Extract of Petroselinum Crispum, Houttuynia Cordata, Mentha Piperita Leaf and Morinda Citrifolia as Active Ingredient | |
KR100878026B1 (en) | Cosmetic composition for skin moisturizing containing thyme extract stabilized with nanoliposomes | |
KR20220026746A (en) | Cosmetic Composition For Moisturizing Skin Comprising Mixed Extracts of Chaenomeles sinensis fruit, Diospyros kaki leaf, Cinnamomum cassia bark, Artemisia princeps leaf, Chrysanthellum indicum and Camellia sinensis leaf as Active Ingredient |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PA0109 | Patent application |
Patent event code: PA01091R01D Comment text: Patent Application Patent event date: 20190527 |
|
PA0201 | Request for examination | ||
PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 20200831 Patent event code: PE09021S01D |
|
PG1501 | Laying open of application | ||
E902 | Notification of reason for refusal | ||
PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 20201230 Patent event code: PE09021S01D |
|
E701 | Decision to grant or registration of patent right | ||
PE0701 | Decision of registration |
Patent event code: PE07011S01D Comment text: Decision to Grant Registration Patent event date: 20210701 |
|
PR0701 | Registration of establishment |
Comment text: Registration of Establishment Patent event date: 20210723 Patent event code: PR07011E01D |
|
PR1002 | Payment of registration fee |
Payment date: 20210723 End annual number: 3 Start annual number: 1 |
|
PG1601 | Publication of registration | ||
PR1001 | Payment of annual fee |
Payment date: 20240627 Start annual number: 4 End annual number: 4 |